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CHAPTER I 
 
INTRODUCTION 
Cellular mRNAs are synthesized in the nucleus and are exported to the 
cytoplasm where they can be actively translated, stored in a dormant form, or 
degraded. From birth to death, each mRNA is bound by an intricate combination 
of RNA binding proteins that regulate mRNA export, transport, localization, 
stability, and translation. Some of the RNA binding proteins, such as the cold-
shock proteins, bind mRNAs with a low degree of sequence-specificity while 
other proteins bind with high specificity to cis-elements in untranslated regions 
(5’UTR or 3’UTR) (Macdonald, 2001; Andreassi and Riccio, 2009).  
mRNA-specific regulatory factors control mRNA fate via recruitment of  
different multi-protein complexes that assemble in a dynamic process regulated 
by different signaling events. In many cases, non-coding RNAs (siRNA or 
miRNAs) can be also recruited to mRNA binding multi-protein complexes (known 
as mRNPs) where they control the mRNA expression. In turn, these complexes 
influence mRNA translation by using different mechanisms including interfering 
with binding of translational factor eIF4E or ribosomal subunits, mediating miRNA 
repression, or controlling cytoplasmic polyadenylation and/or deadenylation 
(Macdonald 2001; Fabian et al., 2010; Groppo and Richter, 2009).  
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Modulating of the length of poly(A) tail is one of the well-described  
mechanism for controlling mRNA translation and stability. Many studies show 
that the shortening of poly(A) correlates with mRNA repression and/or mRNA 
degradation whereas the addition of poly(A) is coincident with active translation 
and protection of mRNA from ribonuclease activity (Richter, 1999; Pique et al., 
2006). There are several known cis-elements in the 3’UTR of mRNA such as the 
Nanos response element (NRE), Pumilio binding element (PBE), embryonic 
deadenylation element (EDEN), AU-rich element (ARE), and Cytoplasmic 
Polyadenylation Element (CPE), all of which were shown to be important for 
shortening of poly(A) tails of its target mRNAs (Macdonald 2001). In addition, 
multiple miRNA-binding sites in 3’UTRs can also mediate inhibition of translation 
via deadenylation.  On the other hand, CPE sequences, in concert with the 
polyadenylation hexanucleotide (HEX), were shown to be important for the 
extension of poly(A) tails (Mendez and Richter, 2001). Moreover, the CPE 
element can perform a dual function through a signal-dependent switch from 
shortening to elongating of mRNA poly(A) tails and therefore from translational 
repression to activation. In some cases, there is a certain degree of synergy 
(e.g., among the CPE, PBE, and HEX) or competition (e.g., between the CPE 
and ARE, or the ARE and miRNAs) between two or more cis-elements, which 
adds an additional level of regulation to mRNA translation (Pique et all., 2008). 
The Cytoplasmic Polyadenylation element (CPE) is a specific U-rich 
sequence (UUUUAAUU or UUUUAU) that is bound by an evolutionarily 
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conserved mRNA binding protein, the Cytoplasmic Polyadenylation Binding 
Protein (CPEB). CPEB possesses two RNA-recognition motifs (RRMs) and two 
zinc-finger motifs that are required for CPE-binding activity (Hake et al., 1998). It 
was shown that phosphorylation of CPEB by the kinase Aurora A shifts CPEB-
dependent shortening of mRNA tails toward their polyadenylation (Mendez et al., 
2000). CPEB was originally discovered and extensively studied in early 
development in Xenopus laevis oocytes where it was found to be a critical factor 
for meiotic progression and oocyte maturation through the regulation of cyclin B1 
and mos mRNAs (Stebbins-Boaz et al., 1996; Mendez and Richter, 2001).  
The observation of CPEB-dependent translational control of these cell 
cycle-related mRNAs in frog oocytes lead to the idea that CPEB could also play a 
role in the mitotic cell cycle in frog embryos  and, perhaps, in mammalian cells. In 
fact, there is growing evidence of CPE- and CPEB-dependent translation, mRNA 
stability, and mRNP transport in rodent cells. CPEB was shown to be involved in 
the cell cycle, synaptic plasticity in neurons (Richter 2007) and, as presented in 
this dissertation, in cellular senescence and LPS-induced inflammation.  
 
The mechanism of CPEB-dependent translation in Xenopus oocytes 
CPEB was originally discovered in the early 1980s in the oocytes of the 
African frog Xenopus laevis. The absence of active transcription in oocytes is 
advantageous  for studying translational control, especially via the regulation of 
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polyadenylation, which is the dominant mechanism of gene expression control in 
early oocytes ( Vassalli et al., 1989; Paris et al., 1988) . Thus, unmatured oocytes 
stay quiescent  for many days in G2-like state and contain a huge pool of 
maternal mRNA being stored in a dormant form with a shortened poly(A) tails 
(about 20-40 adenosines).This supply of dormant mRNAs is important material 
for the future oocyte cell division and promotion of embryonic polarity (Tadros et 
al., 2005).  
At this stage, CPEB binds to CPE-elements (UUUUUAAU) located in 
close proximity to the “nuclear” polyadenylation hexanucleotide sequence 
AAUAAA (HEX), a cis-element that is bound by Cleavage and polyadenylation 
specificity factor (CPSF), and promotes deadenylation of several mRNAs, 
including CyclinB1 and Mos. Mechanistically, CPEB binding to CPE leads to the 
assembly of the large protein complex containing a scaffold protein Symplekin, 
the poly(A) polymerase Gld-2, poly(A) ribonuclease PARN and eIF4E-binding 
protein Maskin. Simultaneous binding of Maskin to CPEB and eIF4E results in 
disruption of eIF4E-eIF4G interaction and in distortion of the “closed loop” 
between 5’-3’ UTRs of mRNA that is necessary for effective 40S ribosomal 
subunit recruitment and initiation of translation. Disruption of the mRNA end-to-
end interaction by Maskin helps PARN to override the activity of GLD2 leading to 
the shortening of the poly(A) tail (Figure 1A) (reviewed in Richter 2007). 
 To reinitiate meiosis and trigger cell cycle progression toward maturation 
into a fertilizable egg, oocytes require stimulation with the hormone 
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progesterone, which boosts polyadenylation of many CPE-containing mRNAs. 
The progesterone signaling cascade activates Aurora A, a kinase that 
phosphorylates CPEB at serine 174, leading to CPEB protein complex 
remodeling (Mendez et al., 2000).The phosphorylation event results in a stronger 
interaction between CPEB, bound to CPE, and CPSF, bound to the HEX. In this 
scenario, PARN gets excluded from the complex, giving the advantage to Gld2 
catalyzed polyadenylation. The newly elongated poly(A) tail (that is about 150 
adenosines long) recruits embryonic polyadenylation binding protein, ePAB  that 
stabilizes poly(A) and, at the same time, interacts with eIF4G by competing 
Maskin out from the binding to eIF4E. Establishing the strong ePAB-eIF4G 
interaction leads to the “closed loop” formation and resumption of efficient mRNA 
translation (Figure 1B) (reviewed in Richter 2007).  
In addition to progesterone, oocyte maturation and CPE-mediated mRNA 
translation can be induced by the insulin signaling pathway via activation of PI3K 
and PKC zeta kinases. Despite different upstream signaling components, both 
progesterone and insulin signaling pathways elicit the activation of GSK-3 kinase, 
which in turn, triggers dissociation and activation of Aurora A from the GSK-
3/Axin/ Aurora A inhibitory complex. Phosphorylation of CPEB by activated 
Aurora A stimulates CPE-dependent mRNA translation of proteins required for 
oocyte maturation, such as Mos and CyclinB1 (Sarkissian et al., 2004).  
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During further cell divisions and progression of oocytes to Meiosis II, 
CPEB level is dramatically reduced  via phosphorylation, subsequent 
ubiquitination and degradation by proteosomal machinery in a SCF (beta-TrCP) 
dependent manner. Degradation of CPEB helps to release a multiple CPE-
containing mRNAs, such as Cyclin B1, from CPEB-mediated control and 
promotes entry into meiosis II (Mendez et al., 2002; Setoyama et al., 2007). 
Importantly, CPEB not only regulates the translational status of CPE-
containing mRNAs, but also localizes its target mRNAs to specific locations such 
as the animal pole of oocytes, embryonic spindles and centrosomes.  Moreover, 
interfering with this “local” embryonic CPEB-dependent translational control by 
depletion of CPEB leads to multiple defects in chromosome segregation, spindle 
formation and cell cycle arrest (Groisman et al., 2000; Eliscovich et al.,2008 ).  
 The number of CPEs in the 3’UTR of an mRNA, their location and 
relationship with the other cis-elements, such as HEX or PBE, were shown to 
influence the CPEB-depenent protein synthesis and differentially regulate mRNA 
translation at different times and locations. Moreover, since many mRNAs 
contain CPEs in their 3’UTR, the combination of additional cis-elements and their 
distance between each other and interacting proteins ensures precise timing and 
specific location of translation for each particular mRNA (Pique et al., 2008).  
Besides factors described above, additional RNA-binding proteins were 
shown to be associated with the CPEB-protein complex, such as frog germ cell-
specific Y-box protein 2 (FRGY2), Xp54 RNA helicase, Pat1, RNA-associated 
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protein 55 (RAP55), CstF77, APLP2, xGEF suggesting existence of a variety 
CPEB complexes whose function still has to be determined (Standart and 
Minshall, 2008). Some of these proteins are known components of mammalian 
mRNP granules such as P-bodies and miRNA complexes. CPEB was also found 
to be localized in mRNA-dependent way to the transcriptionally active lampbrush 
chromosome (Lin et al., 2010). However the function of CPEB1 in this location is 
still unclear. 
 
The Roles of CPEB in Mammalian Cells 
Recently, CPEB was shown to regulate multiple CPE-containing targets in 
mammalian cells where it is involved in different physiological functions (Richter 
2007). Mice lacking CPEB are not only viable but have a normal lifespan, which 
provides a good model for studying CPEB function. However, CPEB knockout 
mouse has impacted fertility due to disruption of synaptonemal complex and 
chromatin fragmentation at the pachytene stage of meiosis (Tay et al., 2001). 
CPEB mRNA and protein are abundant in many mammalian cell types and 
tissues with a highest degree of expression in brain, testis and ovary.  More 
detailed investigations have lead to a growing list of CPEB KO mouse defects 
including changes in learning, memory, senescence and inflammation.  
 Most of the CPEB protein localizes to the cytoplasm, where it can be also 
found as a component of mRNA granules such as processing bodies (P-bodies) 
and  stress granules (SG) (Wilczynska et al., 2005) that are involved in control of 
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mRNA translation and stability (Buchan and Parker, 2009). Both types of 
granules contain dormant mRNA in a form of mRNPs and different proteins. 
Some of these proteins are specific structural components (G3BP in SGs and 
DCP1in P-bodies), where others are transient proteins that have a high 
exchange rate with the cytoplasm (Kedersha and Anderson, 2007).  
 Briefly, P-bodies are the cytoplasmic foci enriched in proteins known to be 
involved in mRNA repression, decaping and degradation (such as decapping 
proteins Dcp1/Dcp2, deadenylase complex CCR4-Not, exonuclease Xrn-1 , RNA 
helicase Dhh1p/rck/p54 protein, and components of miRNA machinery including 
GW182, Ago2 and miRNAs) (Coller and Parker, 2005; Anderson and Kedersha, 
2009). Recently, it was shown that the miRNA pathway leads to mRNA 
repression followed by increased in the P-bodies formation (Jackson and 
Standart, 2007; Fabian et al., 2010). CPEB was shown to co-localize with P-
bodies components, however its function in this foci is not fully described 
(Wilczynska et al., 2005). 
SG granules are larger cytoplasmic granules that are induced by 
environmental stress or by overexpression of some SG proteins. In general, SG 
are considered to be a stalled initiation complexes and they are highly enriched 
in translation initiation factors eIF4E, eIF4G, eIF3 , small ribosomal subunits and  
multiple mRNA binding proteins (FMRP,TIAR,G3BP, CPEB, Y-box protein) 
(Anderson and Kedersha, 2009).  
 9 
Both SG and P-bodies are highly dynamic structures (Balagopal and 
Parker, 2009). First, they are known to interact with each other, as and some 
protein components can be found in both types of granules and can shuttle 
between the two granules (Wilczynska et al., 2005; Buchan and Parker, 2009). 
Second, mRNA repression in these granules was shown to be reversible 
(Bhattacharayaa et al., 2006) and recruitment of some proteins and their mRNA 
targets to the granules is dependent on stimulation (Kedersha and Anderson, 
2007). Finally, all mRNA granules are highly mobile structures that utilize the 
microtubule dependent transport. Moreover, they were found to be attached to 
microtubules and display different types of movements starting from the most 
common oscillatory and retrograde to the less abundant anterograde movements 
(Loschi et al., 2009). Thus, SG and P-bodies can provide a more dynamic and 
versatile directed translational control (Aizer et al., 2008; Anderson and 
Kedersha, 2009). 
The localization of CPEB in cytoplasmic foci seems to be conserved 
among different organisms. Thus, C.elegans and fruit fly CPEB resides in a 
complex with p54 helicase and RAP55 protein as a component of germinal 
granules which consists from some known P-bodies markers and  RNPs involved 
in germ cell development (Standart and Minshall, 2008; Arkov and Ramos, 
2010). In addition, most of the components of CPEB complex in Xenopus 
oocytes also were found to be components of these cytoplasmic structures.  
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Although the function of CPEB in P-bodies and SG is still unknown, it is 
appealing to speculate that CPEB can repress mRNA in these granules (in 
concert with other proteins or miRNAs) until its delivered by microtubule network 
and released to the site of mRNA translation in a certain time point.  
As was discussed above, in Xenopus oocytes and in the variety of 
mammalian cells, CPEB mainly localizes to the cytoplasm. However, upon 
treatment with a chemical inhibitor of the Crm-1-dependent nuclear export 
(Leptomycin B) CPEB accumulates in the nucleus indicating that CPEB is a 
nuclear-cytoplasmic shuttling protein (Ernoult-Lange et al., 2009). The full 
function of CPEB in the nucleus is still under investigation. However, it was 
proposed that CPEB can repress mRNA during nuclear export and also control 
pre-mRNA alternative splicing. In fact, in the nucleus CPEB associates with 
some factors involved in mRNA processing such as Symplekin, Pol II, eIF4AIII, 
Cstf-64 and affects splicing of mouse Col91a gene (Lin et al., 2010).  
 
 The Role of CPEB in Neurons 
The accumulated evidence suggests that translation is required for long 
term memory formation (LTD) and for local protein synthesis in stimulated 
synapses. CPEB is involved in translational control and expressed in the different 
brain regions, with a higher abundance in hippocampus and was shown to be 
involved in regulation of memory formation and synaptic plasticity (Richter and 
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Klan, 2009). Mice lacking CPEB have defects in memory extinction, which is 
likely due to defects in long term potentiation (LTP) and long term depression 
(LTD)(Alarcon et al., 2004; Berger-Sweeney et al., 2006). In addition, CPEB was 
shown to affect dendrite branching, which is known to be important for 
establishing neuronal communications (Bestman and Cline, 2009). Interestingly, 
neurons in the mouse brain contain all important mediators of CPEB-dependent 
translation and respond to multiple signaling pathways, which can potentially lead 
to CPEB-dependent translation in the brain. First, there are many CPE-
containing mRNAs that are activated upon activation of receptors in the brain 
areas with a high abundance of CPEB (Du and Richter, 2005). Second, 
symplekin, poly(A) polymerase, eIF4E and Maskin can also be detected in 
neurons and synapses. Third, the progesterone signaling pathway including 
GSK-3 and Aurora A kinases, is highly active in some areas of the brain such as 
purkinje cells and hippocampus (Yao et al., 2002; Foy et al., 2010; Tsutsui 2008). 
Moreover, neurons in the brain have very active insulin signaling, which was also 
shown to trigger CPEB-dependent translation (Chiu et al., 2010) 
To ensure the local protein synthesis at synapses, mRNA must be 
delivered in a dormant state packed in the form of an mRNP complex (Zukin et 
al., 2009). In neurons there are different types of mRNPs involved in mRNA 
localization, sorting, storing and degradation (transport mRNPs, stress granules 
and P-bodies). All of these granules are highly dynamic structures which can 
possibly exchange some factors between each other. In neuronal dendrites the 
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mRNA granules are localized in both axon and dendrites in a microtubule-
dependent manner and also can be seen at synapses and in 
synaptoneurosomes. These mRNP granules get dramatically reduced in a 
number after electrical depolarization of cultured neurons, which correlates with a 
increased turnover rate of structural components of P-bodies (Zeitelhofer et al., 
2008). Recently published study in Aplysia sensory neuron, found CPEB in 
mRNA granules similar to SG which increases in size and shows the decreased 
mobility upon stimulation (Si et al., 2010; Chae et al., 2010).  
In neurons, CPEB binds CamKII 3’UTR within the transport granules and 
delivers mRNA in a microtubule dependent manner. The regulation of CaMKII 
mRNA by CPEB was shown to be CPE-dependent and activated by the NMDA 
signaling cascade (Wu et al., 1998; Huang et al., 2003). Additional studies show 
that deletion of CPEB affects the transport of mRNA granules and leads to 
defects in dendrite branching. Besides CamKII, many more potential neuronal 
CPE-containing targets of CPEB were identified (BDNF and c-jun, tPA, 
engrailed1) and more mRNAs were proposed as potential CPEB targets (Oe and 
Yuneda, 2010; Du and Richter, 2005).   
Taking into account the abundance of CPEB in the brain together with the 
fact that multiple neuronal mRNAs contain CPE-elements, CPEB might have a 
potential role in many neurological functions.  
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Figure 1. Translational control by CPEB in early development. 
CPEB bound to the CPE element recruits multiple factors resulting in 
translational arrest of mRNA with a short polyA tale (A). Stimulation with 
progesterone or insulin activates Aurora A which phosphorylates CPEB and 
triggers CPEB protein complex remodeling resulting in resumed polyadenylation 
and translation (B) (See detailed description in the text (p.4-5)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
Senescence 
 
Mouse Embryonic Fibroblasts (MEFs) are the classical model for 
characterization of senescence associated signal transduction, oxidative stress 
and tumorogenesis. Newly established fibroblast cell cultures can replicate 
normally for a several passages, slowly progressing toward the abrupt 
irreversible growth arrest, known as senescence. Senescent cells display 
flattened cell morphology, senescence-associated heterochromatin foci, and 
express a high level of senescence-associated acidic β-galactosidase and stay 
arrested for many days (Sharpless et al., 2001). Finally, they may acquire 
multiple genetic alterations and can reinitiate replication, a transition point known 
as the senescence bypass or immortalization. Therefore, cellular senescence is 
considered to be a protective mechanism from uncontrolled proliferation and 
received considerable attention due to its antitumorigenic effect. From the other 
hand, bypass of  senescence and immortalization leads to unlimited cell divisions 
and higher susceptibility to transformation and cancerogenesis (Braig et al., 
2005;Chen et al., 2005;Collado et al., 2005).  
In regular cell culture conditions, naturally accruing oxidative stress is the 
major cause of cellular senescence since the cells that cultured in oxygen 
restricted environment proliferate for an indefinite amount of passages.  
Senescence can be also stimulated by the application of excessive   DNA 
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damaging stress such as UV, X-ray, and Hydroperoxide or by overexpression of   
some oncogenes and tumor suppressors (Ben-Porath and Weinberg, 2005).  
Despite the fact that mouse cell senescence is telomere-independent and 
has an early onset (about 10 passages in cell culture), when the human cell 
senescence depends on telomere erosion and has a later onset (about 70 
passages in cell culture), both human and mouse cells have two major 
senescence pathways, p16INK4a/Rb and p19ARF/p53/ (Fig.2). 
 
p16INK4a/Rb pathway 
RB protein regulates the G1/S transition stage of cell cycle by controlling the E2F 
transcription factor. Briefly, the cell-cycle controlled regulation of cyclin-
dependent kinases (CDKs) such as CDK4, CDK6, and CDK2 lead to 
phosphorylation of Rb, thus controlling its activity. In turn, phosphorylated Rb is 
not able to repress the E2F transcription factors, which mediates the expression 
of multiple genes involved in G1/S progression of cell cycle such as cyclin E and 
cyclin A. The p16 protein is the cyclin dependent kinase inhibitor  that prevents  
Rb phosphorylation via inhibition of CDKs. Elevated level of p16, overexpression 
of RB, or inhibition of E2F are strongly associated with growth arrest and cellular 
senescence ( Campissi, 2003; Sherr 2004).  
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This pathway is activated by p19ARF, which triggers inactivation of MDM2, a 
protein that is involved in degradation of the tumor suppressor gene p53. 
Activated p53 triggers expression of many genes involved in cell proliferation 
arrest and apoptosis. The cell cycle inhibitory function of p53 is mediated via 
regulation of protein p21, the cyclin dependent kinase inhibitor that alters 
CDK2/cyclin-E and CDK4/cyclin-D activity. p53 is a very strong tumor suppressor 
and its inactivation leads to the development of multiple cancers. Conversely, 
overexpression of p53 leads to growth arrest and prevents tumorigenesis (Sherr 
2004).  
 
p19ARF/p53/p21 pathway 
RAS proteins belong to the family of small GTPases that includes three family 
members such as H-RAS, K-RAS and N-RAS. RAS protein is a very potent 
oncogene and its hyperactivation ultimately lead to many cancers. Transfection 
of immortalized cells with RAS also leads to the tumorigenic phenotype. 
However, if introduced to the primary cells in the early passages RAS induces 
premature senescence triggering the accumulation of tumor suppressors p53 
and p16INK, providing a classical example of oncogene induced senescence 
(OIS). RAS-induced senescence was shown to require the activation of 
RAS oncogene 
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RAF/MEK/ERK and/or PI3K/AKT pathways, which components are known play a 
critical role in cell proliferation and differentiation (Serrano et.al., 1997). 
In addition to the RAS oncogene, overexpression of the transcriptional factor c-
Myc, also block proliferation of  primary cells due to its pro-apoptotic effect 
mediated by enhanced transcription of p19ARF and a subsequent stabilization of 
p53 (
Myc oncogene 
Zindy et al., 1998). However, the normal function of c-Myc oncogene is to 
enhance cell proliferation and its overexpression can promote immortalization 
and tumorigenesis in cells with altered   p19ARF/p53 pathway. In fact, the 
increased level of c-Myc was found in many types of tumors (Nesbit et al., 1999). 
From the other hand, c-Myc deficiency leads to a dramatic reduction in 
proliferation rate due to very low levels of CDK4–6/D and CDK2/E activity 
(Mateyak et al., 1999). Many cell cycle related genes such as CDK2-activating 
phosphatases Cdc25A and B, E2F-2 and D-type cyclins are known 
transcriptional targets of c-Myc (Dang et al., 1999; Cole et al., 1999) 
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Figure  2.  Molecular  pathways of cellular senescence. Senescence signals 
triggered by genotoxic or oxidative stress, UV, DNA damage or by oncogene 
overexpression activate p19ARF/p53/p21 or p16INK4a/Rb pathways (see pathway 
description in the text (p.16-17)) leading to the growth arrest, apoptosis 
resistance and senescence. 
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Inflammation 
 
Microbial and viral infections, as well as different types of tissue injuries 
including cardiac infarction and ischemia, are counteracted by an acute immune 
response that protects the organism from harmful stimuli and initiates the healing 
process (Medzhitov 2008; Akira et al., 2006; Gueler et al., 2004). Despite its 
protective role, not properly terminated or excessive inflammation can cause 
endotoxic shock, a life threatening condition that leads to detrimental tissue 
damage of multiple organs (Aggarwal et al., 2003; Gerber and Nau, 2010). 
The inflammatory response is regulated by cytokines and chemokines, 
small secreted proteins that act on immune system pathways in picomolar 
concentrations by binding to specific cell-surface receptors (Dinarello et al., 2004; 
Conti et al., 2004). The expression of these signaling molecules is a time-
dependent event that is tightly regulated at the level of transcriptional activation 
and repression, as well as at the level of mRNA stability and translational control 
(Hao and Baltimore,2009; Anderson, 2009). High level of cytokines, or their 
prolong expression, strongly correlates with increased mortality due to the septic 
shock (Gullo et al., 2010; Krakauer et al., 2010; Brunialty et al., 2006). In addition 
to the acute inflammatory response, unregulated production of proinflammatory 
cytokines and chemokines can lead to chronic inflammation, a hallmark of many 
diseases such as diabetes, cancer, asthma, obesity, arthritis, atherosclerosis and 
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neurodegeneration (Tracey et al.,1993; Pickup, 2004; Dandona et al., 2004; 
Philip et al., 2004, Phillips et al., 2004). 
 
In bacterial infection, an inflammatory signaling cascade can be triggered 
by liposaccharide (LPS), an endotoxin derived from bacterial walls. Injection of 
LPS into mice dramatically induces the level of proinflammatory IL-6 in serum, 
which is one of the first response cytokines whose level is highly correlated with 
the severity of the endotoxic stress. Inflammation is characterized by increased 
blood flow and capillary permeability and the recruitment of polymorphonuclear 
granulocytes (neutrophils), cells with high phagocyte activity, blood monocytes, 
which can differentiate into macrophages, and dendritic cells.  Cytokines are 
secreted by all three cell types (Janeway et al., 2005). Macrophages also display 
phagocytic activity and because of their long life span, play important roles during 
the immune response (
LPS signaling pathway 
Gordon and Taylor, 2005).  At the cell surface, LPS 
interacts with LPS binding protein, which together bind CD14 and myeloid 
differentiation factor 2 (MD2). This protein complex engages the TLR4 receptor 
and facilitates the activation and subsequent nuclear translocation of the first 
response transcription factors including AP-1, NFκB, C/EBPb, c-Jun, STATs, and 
IRFs (Akira et al., 2001; Kawasaki et al., 2003). These transcription factors act in 
combinatorial fashion to insure a fast immune response.  
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Activated TLR4 receptor elicits a downstream signaling cascade through 
MyD88-dependent pathway. This pathway starts when MyD88 (an adaptor 
protein) engaged by TLR4 recruits multiple additional adaptors and activates a 
number of kinases including IKK (leading to NFκB activation), MKK3/6 (leading to 
activation of p38), and MKK4/7 (which activates JNK). 
 
Uncontrolled activation of NFκB ultimately leads to multiple inflammatory 
disorders including autoimmune diseases and septic shock (Tak et al., 2001). In 
addition, sustained NFκB activation is found in many types of cancers (Karin et 
NFκB transcription complex 
NFκB (nuclear factor kappa-light chain-enhancer of activated B cells) is an 
evolutionarily conserved transcription factor that is activated via different 
pathways by multiple stimuli. It contributes to diverse cellular processes such as 
cellular proliferation and stress response, cell death, and inflammation (Barnes et 
al., 1997; Pachl et al., 1999; Lappas et al., 2002).  NFκB can activate or repress 
gene expression through its binding to the specific DNA sequences within 
promoters and enhancers known as κB elements. Activation of NFκB leads to 
the increased transcription of different inflammation mediators including IL-1, 
TNFα, IL-6, IL-8, and enzymes such as cyclooxygenase-2 (COX2) and iNOS 
(Hoffmann et al., 2006; Pahl et al., 1999), which, in turn, can further propagate 
NFκB  activation (Barnes and Karin, 1997). 
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al., 2006). Conversely, the inhibition of NFκB during bacterial induced 
inflammation leads to the reduced production of proinflammatory proteins and 
decreased neutrophil infiltration. There are a growing number of NFκB inhibitors 
that can reduce NFκB activation and cytokine production (Ivanenkov et al., 
2008).  
NFκB is a family of proteins containing similar N-terminal Rel homology 
domains (RHD) that are important for dimerization and DNA binding.  The family 
has five members: RelA (p65), RelB, c-Rel, NFκB1 (p50/p105) and NFκB2 
(p52/p100). Based on their structure, the first three proteins can be grouped 
together because they all posses a common inhibitory c-terminal ankyrin motif. 
In contrast, p100 (precursor of p52) and p105 (precursor of p50) has to be 
processed by limited proteolysis ( Nolan and Baltimore, 1992; Hoffmann et al., 
2002; Karin,2006) or by translational inhibition (Moore et al., 1999) to generate 
active shorter proteins.  
All NF-kb family members act as dimers (homo- or hetero-) that have 
different DNA binding specificities, transcriptional activities, and mechanisms of 
activation (Ghosh et al., 2005). The RelA, RelB, and c-Rel transactivation 
domains (TAD), which are responsible for engaging co-activators and displacing 
repressors, function as transcriptional activators. In contrast, both p50 and p52 
proteins, which lack transactivation domains and are present as homodimers, 
can only act as repressors. However, they can activate transcription when 
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heterodimerized with TAD-containing proteins such as Bcl-3 or other members of 
the NFκB family. (Baeuerle and Henkel,1994).  
 
Mechanism of the NFκB activation 
At steady state in unstimulated cells, the NFκB heterodimer 
RelA(p65)/p50 localizes in the cytoplasm via interaction with inhibitory proteins 
from the IκB family. This family includes seven members: IκBα, IκBβ, IκBγ, BCL-
3, IκBε, and the precursor proteins p100 and p105, all of which contain a 
conserved c-terminal ankyrin repeats sequence. These ankyrin repeats mask the 
nuclear localization sequence (NLS) of RelA, thus preventing its nuclear 
translocation (Stancovski and Baltimore, 1997; Xiao and Ghosh, 2005).  Upon 
LPS signaling, IκBα is hyperphosphorylated by activated inhibitor of κB kinase 
(IKK), and is rapidly degraded by the proteasome in a ubiquitin-dependent 
fashion (DiDonato et al., 1997). The exposed NLS domain of NFκB directs its 
nuclear translocation followed by DNA-binding to promoter regions. Therefore, 
the balance between synthesis and degradation of IκBα is critical for NFκB 
activation. Newly synthesized IκBα then binds NFκB and brings it back to the 
cytoplasm. These events are classified as the canonical NFκB activation 
pathway, which is the major pathway induced by LPS. Alternatively, IKK activity 
can trigger a noncanonical pathway via enhanced p100 processing to p52 
(Scheidereit et al., 2006) 
 26 
 
IKK complex 
The IKK complex consists of three major kinase subunits: IKKα (IKK1), 
IKKβ (IKK2), and NEMO or IKKγ.  The IKKα and IKKβ subunits, when in 
heterodimer form, directly phosphorylate S32 and S36 residues of IκBα. IKKγ has 
no enzymatic activity but coordinates upstream signaling pathways. In the 
canonical pathway, the IKK complex is activated by kinases such as TAK1, which 
phosphorylates IKKβ on residues Ser177 and Ser181 (Mercurio et al., 1997; 
Hoffmann et al., 2002). This posttranslational modification is not only necessary 
but sufficient for phosphorylation of IκBα on Ser32/36 (Zandi et al., 1997). Upon 
phosphorylation, the IκBα become ubiquitinated (by Skp1–Culin Roc1/Rbx1/Hrt-
1–F-box, which belongs to the SCF family of ubiquitin ligases) followed by 
proteosomal degradation (Ben-Neriah, 2002). In contrast, activated IKKα triggers 
an alternative noncanonical pathway whereby proteosomal processing of p100 
elicits p52-RelB heterodimer formation and nuclear translocation (Karin, 2006).  
 
In addition to transcriptional control, mammalian cells display a variety of 
post-transcriptional mechanisms that mediate the inflammatory response. This 
additional level of regulation occurs by way of regulatory elements in the 3’UTRs 
of particular mRNAs. These 3’UTR elements control the timing and extent of 
Posttranscriptional regulation of inflammation 
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mRNA destruction and/or translation, thereby providing strong temporal control of 
the immune response.  Based on the time at which they are activated, the genes 
can be subdivided into three groups, the first of which consist early response 
genes, which are induced within an hour after stimulation. This group encodes a 
number of mRNAs with cis-elements (AU-rich elements, or AREs), which are 
involved in mRNA stability. The second and third groups represent intermediate 
(at 2 hours after stimulation) and late (by 12 hours) response genes (Hao et al., 
2009). 
The ARE-binding proteins (TTP, TIA-1, AUF1, HuR) are essential cis-factors 
involved in the stability and translational repression of ARE-containing mRNAs 
Deficiency in ARE binding proteins usually leads to the multiple inflammatory 
conditions, most often, due to increased stability of cytokine TNFα mRNA The 
cytokine production is also regulated via miRNAs which act in concert with RNA 
binding proteins (Zhang et al., 2002; Anderson, 2010). 
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Abstract 
 
Cytoplasmic polyadenylation element-binding protein (CPEB) is a 
sequence-specific RNA-binding protein that promotes polyadenylation-induced 
translation. While a CPEB knockout (KO) mouse is sterile but overtly normal, 
embryo fibroblasts derived from this mouse (MEFs) do not enter senescence in 
culture as do wild-type MEFs, but instead are immortal. Exogenous CPEB 
restores senescence in the KO MEFs and also induces precocious senescence 
in wild-type MEFs. CPEB cannot stimulate senescence in MEFs lacking the 
tumor suppressors p53, p19ARF, or p16INK4A; however, the mRNAs encoding 
these proteins are unlikely targets of CPEB since their expression is the same in 
wild-type and KO MEFs. Conversely, Ras cannot induce senescence in MEFs 
lacking CPEB, suggesting that it may lie upstream of CPEB. One target of CPEB 
regulation is myc mRNA, whose unregulated translation in the KO MEFs may 
cause them to bypass senescence. Thus, CPEB appears to act as a translational 
repressor protein to control myc translation and resulting cellular senescence. 
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Introduction 
 
Regulated mRNA translation plays an important role in early animal 
development and in the central nervous system. In oocytes, embryos, and 
neurons, several dormant mRNAs have short poly(A) tails; when the poly(A) tails 
are elongated in response to external stimuli, translation ensues (Wu et al. 
1998; Groisman et al. 2002). The cytoplasmic polyadenylation element-binding 
protein (CPEB) is the key factor that controls this process; it binds the 
cytoplasmic polyadenylation element (CPE) in the 3′ untranslated regions (UTRs) 
of responding mRNAs. When phosphorylated on S174 or T171 (species-
dependent), CPEB promotes polyadenylation by stimulating the activity of Gld-2 
(Barnard et al. 2004), an atypical poly(A) polymerase (Kwak et al. 2004). The 
newly elongated tail then is bound by poly(A)-binding protein (PABP), which 
promotes general translation by augmenting the assembly of the eIF4F initiation 
complex (Kahvejian et al. 2005). How the poly(A) tail and PABP stimulate 
translation of CPE-containing RNAs was revealed when a CPEB 
coimmunoprecipitating protein was identified. This protein, Maskin, binds not only 
CPEB, but also the cap-binding factor eIF4E (Stebbins-Boaz et al. 1999; Richter 
and Sonenberg 2005). The Maskin–eIF4E association competitively inhibits the 
eIF4E–eIF4G association; thus, there is no eIF4G-assisted recruitment of the 
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40S ribosomal subunit to the 5′ end of the mRNA. The poly(A) tail and PABP help 
eIF4G out-compete Maskin for binding to eIF4E, which results in eIF4F initiation 
complex assembly and translation (Cao and Richter 2002). Maskin 
phosphorylation also helps this protein dissociate from eIF4E (Barnard et al. 
2005). 
In early-stage embryos of Xenopus laevis, CPEB promotes 
polyadenylation-induced translation of cyclin B1 mRNA, which helps drive these 
atypical mitotic cell cycles that lack G1 and G2 phases (Groisman et al. 2002). 
Indeed, the injection of neutralizing CPEB antibody or dominant-negative mutant 
forms of this protein inhibits cell division (Groisman et al. 2000; Mendez et al. 
2002). In contrast to these results in Xenopus, CPEB knockout (KO) mice are 
viable and appear overtly normal, although they have defects in germ cell 
development (Tay and Richter 2001; Tay et al. 2003) and neuronal synaptic 
plasticity (Alarcon et al. 2004) and exhibit some behavioral anomalies (Berger-
Sweeney et al. 2006). The observations that CPEB is essential for mitotic 
progression in Xenopus embryos and that mice lacking this gene display no 
phenotype that is obviously related to aberrant cell cycle progression might seem 
contradictory. However, some genes that are important for cell cycle progression 
in cultured cells have little effect in KO mice (Sherr and Roberts 2004;Malumbres 
and Barbacid 2005). To determine whether CPEB is important for cell cycle 
progression in mice, embryo fibroblasts (MEFs) from wild-type and CPEB KO 
animals were cultured according to a standard 3T3 protocol; there were no 
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detectable differences in cell division. However, several passages after the initial 
cell cycle experiments were performed, the wild-type cells ceased to divide and 
entered a senescent stage, as expected (Sharpless et al. 2001). Amazingly, the 
KO MEFs did not senesce, but instead bypassed this process and were immortal 
up to at least 40 passages. 
Senescence is a process that limits the number of times a cell divides in vitro; in 
mouse cells, it can be induced by DNA damage, the activation of certain 
oncogenes, or the stress of certain culture conditions (Ben-Porath and Weinberg, 
2005). In vivo, senescence may be a tumor-suppression mechanism to prevent 
malignant transformation (Braig et al. 2005;Chen et al. 2005;Collado et al. 
2005;Michaloglou et al. 2005) and contribute to organismal aging (Patil et al. 
2005). While several genes influence senescence, perhaps the most central are 
the tumor suppressors p53, Rb, p19ARF, and p16INK4A. While p19ARF and 
p16INK4A are derived from the same locus, p16INK4A is a cyclin-dependent kinase 
(CDK) inhibitor and thus an activator of Rb, a transcriptional corepressor. 
p19ARF activates the transcription activator p53 by antagonizing Mdm2, the 
ubiquitin ligase that mediates its destruction (Sherr 2004). Primary mouse cells 
that lack either of the abovementioned four tumor suppressors are immortal 
(Campisi 2003; Sherr 2004). 
While exogenous CPEB restored senescence when expressed in CPEB KO 
MEFs and even induced precocious senescence in wild-type MEFs, it could not 
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induce senescence in p53, p19ARF, or p16INK4A/p19ARF double-KO MEFs. 
Conversely, activated Ras, which induces senescence in wild-type MEFs, could 
not do so in CPEB KO MEFs. The CPEB KO MEFs yielded a few small foci when 
grown in soft agar, suggesting that they may be partially transformed; however, 
they did not yield tumors when injected into athymic (nude) mice. p53, Rb, 
p19ARF, and p16INK4A were all expressed in CPEB KO MEFs at levels similar to 
those observed in wild-type MEFs, although the Rb pocket proteins showed 
some changes. On the other hand, myc levels were aberrantly high in the KO 
MEFs, indicating that the mRNA encoding this protein might be misregulated in 
the KO MEFs. Indeed, myc RNA coimmunoprecipitates with CPEB from wild-type 
MEFs, and the CPE-containing myc 3′ UTR, when appended to a reporter RNA, 
is responsible for elevated levels of translation in KO versus wild-type MEFs. 
Moreover, the elevated expression of myc in the wild-type MEFs may cause 
them to bypass senescence. These and other data suggest that CPEB-mediated 
down-regulation of translation is necessary for mouse cells to become 
senescent. 
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Results 
 
CPEB regulates cell senescence 
To determine whether CPEB is important for the cell cycle, mouse embryo 
fibroblasts (MEFs) were prepared from embryonic day 14.5 (E14.5) embryos. At 
passage 2, the cells were cultured in medium lacking serum for 24 h and then 
cultured a subsequent 29 h in medium containing 10% serum. At several times, 
the cells were subjected to FACS analysis; both wild-type and KO MEFs 
recovered from quiescence induced by serum deprivation in an identical manner 
(Supplementary Fig. 1). 
Wild-type and KO MEFs were further cultured according to a standard 3T3 
protocol. A Western blot of the KO MEFs confirms that they do not express 
detectable levels of CPEB (Fig. 1A, left). Growth curves of four KO MEF lines 
show that they all bypassed senescence, while a wild-type line senesced after 
passage 6 (Fig. 1A, right). In other experiments, 14 of 17 KO MEF lines were 
found to be immortal, while seven of seven wild-type lines became senescent 
(data not shown). Although only 12 passages are depicted in the figure, the KO 
MEFs have been cultured up to ~40 passages, demonstrating that they are 
immortal. A heterozygous MEF line also was immortal, indicating that the amount 
of CPEB is important for senescence (Fig. 1A). In other experiments, five of five 
additional heterozygous MEF lines also were immortal (data not shown). 
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To assess whether the KO MEFs were immortal because they lacked CPEB and 
not because of a mutation elsewhere in the genome, the KO MEFs were infected 
with a retrovirus expressing CPEB or, as a control, an empty virus. CPEB caused 
the KO MEFs to stop dividing, express senescence-associated β-galactosidase, 
and assume a flattened morphology typical of senescent cells (Ben-Porath and 
Weinberg 2005). Moreover, CPEB caused wild-type MEFs to undergo 
senescence prematurely (passage 4 instead of passage 7) and to express β-
galactosidase (Fig. 1B; at right, a Western blot shows that similar amounts of 
heterologous CPEB were synthesized in wild-type and KO MEFs). In other 
experiments, late (more than ~25) passage KO MEFs or immortalized cells 
derived from wild-type MEFs infected with the same CPEB-expressing retrovirus 
elicited no discernible effect on cell division or morphology (data not shown). 
Therefore, this rescue experiment demonstrates that CPEB is essential for cell 
senescence and eliminates the possibility that the senescence bypass in the KO 
MEFs was caused by mutations in other genes. 
To gain insight into other genes that might act in concert with CPEB, we 
considered three that are known to be necessary for senescence: p53, p19ARF, 
and p16INK4A. We obtained MEFs that lack p53, p19ARF, or p19ARF and p16INK4A, 
which when cultured according to our 3T3 protocol, were, indeed, immortal (Fig. 
1C). While CPEB induced the premature senescence of wild-type MEFs at 
passage 4 (as noted in Fig. 1B), it could not rescue senescence in MEFs that 
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lack these three genes (cells infected at passage 4 and examined at passage 
11). Thus, CPEB requires these tumor suppressors to induce senescence. 
Finally, we determined whether oncogenic Ras, which induces premature 
senescence in mouse primary cells (Serrano et al. 1997), could also do so in 
cells that lack CPEB. CPEB KO and wild-type MEFs, as well as p19ARF KO 
MEFs, were infected with a retrovirus expressing Ki-Ras at passage 2, subjected 
to antibiotic selection at passage 3, and examined at passage 5. While this 
protein induced senescence of wild-type cells, it did not do so with the p19ARF or 
CPEB KO MEFs (Fig. 1D). Thus, Ras-induced senescence cannot overcome the 
loss of these proteins. 
 
Transformation potential of CPEB KO MEFs 
The observation that CPEB KO MEFs are immortal suggests that they might 
display some features of a transformed phenotype. We examined four 
parameters to assess whether the KO MEFs might be at least partially 
transformed. First, transformed cells often display an elongated morphology; 
however, in contrast to immortalized cells derived from wild-type MEFs or early-
passage wild-type and KO MEFs, late-passage KO MEFs had a distinctive round 
shape (Fig. 2A) that is not obviously related to partial transformation. Second, 
another assay to identify transformed cells is their ability to grow in medium 
containing reduced serum, typically 1%. Under this culture condition, neither the 
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KO nor the wild-type MEFs grew irrespective of whether they were infected with 
a Ras-bearing retrovirus (Fig. 2B). However, when the medium contained the 
normal 10% serum, the KO MEFs grew at a faster rate than immortalized cells 
derived from wild-type MEFs with or without exogenous Ras expression. These 
results suggest that the KO MEFs might have a tendency toward transformation. 
Third, we examined the ability of the KO MEFs to grow in soft agar, which is a 
widely used indicator of transformation. While immortalized cells derived from 
wild-type MEFs did not form any colonies in this medium, the KO MEFs did, 
although the colonies were small and not abundant (Fig. 2C). When transformed 
with Ras, the immortalized cells derived from wild-type MEFs and the KO MEFs 
both formed large and numerous colonies, although the latter were larger and 
more numerous. These data also suggest a tendency of KO MEFs toward 
transformation. Fourth, we determined whether late-passage (immortal) KO 
MEFs formed tumors in nude (athymic) mice. For comparison, immortalized cells 
derived from wild-type MEFs as well as both cell types transformed with Ras 
were also injected into nude mice. No tumors were observed in animals injected 
with immortalized KO or wild-type cells (data not shown), but as expected, 
tumors were evident in animals injected with cells (wild-type and KO) that were 
transformed with Ras (Fig. 3A). Curiously, the 10 tumors derived from the KO 
MEFs all had large hematomas, while none of the 10 tumors derived from wild-
type cells were so distinguished (Fig. 3A, arrows). Although the tumors appeared 
to grow at the same rate (Fig. 3B), the final weights (after 36 d of growth) of the 
 38 
wild-type tumors were usually greater than the KO tumors (Fig. 3C) (p = 0.01, 
Student's t-test). Moreover, the morphologies of the tumors were different; the 
cells containing CPEB were densely packed and slightly elongated, while those 
lacking CPEB were larger, more irregularly shaped, and with nuclei usually 
displaced to the periphery (Fig. 3D). While the significance of these morphology 
differences remains to be elucidated, the aggregate data indicate that the CPEB 
KO MEFs are probably not transformed unless they are challenged with an 
oncogene. 
 
Altered levels of senescence-associated proteins in CPEB KO MEFs 
To examine whether key proteins that are thought to influence senescence are 
aberrantly expressed in the KO MEFs, a series of Western blots was performed 
(Fig. 4). The levels of p53, p19ARF, p16INK, and Rb (unphosphorylated and 
phosphorylated forms) were nearly the same in wild-type and KO MEFs, 
indicating that they are unlikely to be substrates of CPEB regulation. Note that 
the p53 antibody reacted with two proteins from wild-type and KO MEFs; to firmly 
identify p53, protein from p53 KO MEFs was also analyzed in parallel lanes, 
which demonstrated that the indicated band is, indeed, p53 and that it was 
present at similar levels in wild-type and KO MEFs. Myc as well as the Rb pocket 
proteins p130 and 107 were present at higher levels in the KO MEFs and all 
have putative CPEs (Fig. 4), suggesting that aberrant translation of one or more 
of them in the KO MEFs might be responsible for senescence bypass. 
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The overexpression, not underexpression, of these proteins in the KO MEFs was 
a surprising finding. For example, the ablation of CPEB activity 
in Xenopus oocytes or embryos prevents translation (Groisman et al. 
2000; Mendez et al. 2002) as does the removal of CPEB from oocytes of KO 
mice (Tay and Richter 2001). Thus, in these cases, CPEB is an activator of 
translation. Moreover, CPEB-stimulated translation requires phosphorylation of 
S174 or T171 (Xenopus and mouse, respectively) (Mendez et al. 2000; Tay et al. 
2003). To assess whether CPEB-controlled senescence requires RNA binding 
and/ or T171 phosphorylation, the KO MEFs were infected with retroviruses 
expressing wild-type and deletion mutant CPEB proteins. Figure 5 shows that 
while wild-type CPEB rescued senescence in KO MEFs, CPEB proteins lacking 
either the two RNA-binding domains or the zinc finger, all of which are necessary 
for RNA binding (Hake et al. 1998), failed to do so. Conversely, CPEB with a 
T171A mutation did rescue senescence (this construct also contained an S177A; 
while there is no evidence that this residue is phosphorylated, the motif in which 
this residue lies strongly resembles that surrounding T171 and thus could be a 
secondary phosphorylation site). Therefore, while RNA binding is necessary for 
CPEB-mediated senescence, T171 phosphorylation is not. Because this 
modification is required for polyadenylation (at least in oocytes and probably 
neurons as well), it may be that in MEFs, CPEB-regulated translation might not 
require polyadenylation. 
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CPEB inhibits myc RNA translation 
To identify possible mRNA substrates of CPEB in MEFs, we performed a series 
of ribonucleoprotein (RNP) coimmunoprecipitation experiments. MEFs were 
infected with viruses expressing HA-CPEB (HA antibody precipitation is more 
efficient than CPEB antibody precipitation), followed by immunoprecipitation, 
RNA extraction, and RT–PCR detection of RNAs selected on the basis of their 
expression in MEFs and whether they have putative CPEs (Fig. 6A). RNAs 
encoding the Rb pocket proteins p107 and p130 and myc were 
immunoprecipitated with HA-CPEB (Fig. 6A, lane 2, cf. lane 1, where HA was 
immunoprecipitated from uninfected cells.) RT– PCR of a serial dilution of total 
RNA indicates the relative amount of the precipitated RNA (Fig. 6A, lanes 3–6). 
In addition, the RNA levels were the same in wild-type and KO MEFs and in KO 
MEFs infected with the CPEB-containing virus (Fig. 6A, lanes 7–9). Controls in 
which the reverse transcription step was omitted did not yield amplification 
products (data not shown). These data show that some, but not all, CPE-
containing RNAs can be immunoprecipitated with CPEB. 
Because Rb protein levels were the same in wild-type and KO MEFs, the RNA 
encoding this protein is unlikely to be regulated by CPEB. On the other hand, the 
levels of p107, p130, and myc were all elevated in the KO MEFs (Fig. 4). Any of 
these proteins could contribute to senescence bypass; however, p107 and p130 
have been knocked out in mice with no reported precocious MEF senescence 
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(Sage et al. 2000), which would be expected if they were the direct downstream 
effectors of CPEB. (Note, however, that while oncogenic Ras induces 
senescence in Rb KO MEFs, it cannot induce senescence in Rb/p107 or 
Rb/p107/p130 KO cells, thereby demonstrating the involvement of the pocket 
proteins in senescence [Sage et al. 2000; Pepper et al. 2001].) Because myc has 
been reported to be involved in senescence (Lutz et al. 2002) and because high 
levels of myc are detected in the CPEB KO MEFs that bypass senescence, we 
have focused our initial attention on this mRNA. 
A UV cross-linking experiment was used to determine whether myc RNA is a 
direct target of CPEB. Recombinant CPEB was mixed with the myc 3′ UTR that 
was synthesized in vitro in the presence of [32P]UTP. In some cases radioinert 
competitor RNA lacking or containing the CPE was also added to the mix, which 
was followed by UV irradiation, RNase digestion, and analysis by SDS-PAGE 
and PhosphorImaging (Fig. 6B). CPEB was efficiently cross-linked to the RNA, 
which was reduced only when the competitor RNA contained a CPE. Thus, 
CPEB directly interacts with the myc 3′ UTR CPEs. 
Next, we repeated the CPEB-myc RNA coimmunoprecipitation experiment from 
MEFs as in Figure 6A, but in this case, excess competitor RNA lacking or 
containing the CPE was added to the extract prior to and during the 
immunoprecipitation procedure (Fig. 6C). The CPE-containing RNA effectively 
competed away the myc RNA from binding CPEB, while the CPE-lacking RNA 
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had no effect. These data indicate that CPEB interacts with the myc 3′ UTR 
CPEs in MEFs. 
To confirm that the translation of myc RNA is regulated by CPEB, as suggested 
by the data in Figure 4, extracts from wild-type and KO MEFs were centrifuged 
through sucrose gradients to resolve the polysomes and the nontranslating 
RNPs, which generally sediment less than 80S. The RNA was extracted from 
each fraction and subjected to real-time quantitative RT–PCR for actin and myc 
RNAs. When compared with actin RNA (whose sedimentation did not change in 
the wild-type vs. KO MEFs) (data not shown), the results in Figure 6D show that 
in wild-type MEFs, a substantial portion of myc RNA was not translated, but that 
much of this material was recruited into polysomes in the KO MEFs. Thus, CPEB 
appears to repress the translation of myc RNA. 
Finally, a reporter Renilla luciferase RNA was appended with either this 
sequence or a control vector sequence; plasmid DNAs encoding these RNAs, 
together with one encoding firefly luciferase to serve as an internal standard, 
were transfected into wild-type and CPEB KO MEFs followed by an analysis of 
luciferase activity. While both MEF types translated the RNA with the vector 3′ 
UTR to about the same extent, the KO MEFs translated the RNA with the myc 3 ′ 
UTR with greater efficiency than wild-type MEFs (Fig. 6E). Taken together, the 
results in Figure 6 demonstrate that CPEB inhibits myc mRNA translation. 
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The regulated translation of Myc RNA by CPEB controls cell senescence 
Plasmid DNA encoding myc RNA with its own 3′ UTR or one composed of vector 
sequence was transfected into wild-type and CPEB KO MEFs; DNA encoding 
vector sequence was also transfected. While none of the RNAs had an effect on 
growth of the CPEB KO MEFs, myc RNA with the vector 3′ UTR caused the wild-
type cells to bypass senescence when compared with the RNA encoding myc 
with its own 3′ UTR or the noncoding RNA (Fig. 7A). Moreover, a Western 
analysis for Myc shows that the levels of this protein were high in wild-type MEFs 
transfected with myc RNA with the vector 3′ UTR, but lower in wild-type MEFs 
transfected with the other RNAs; Myc was also high in KO MEFs under all 
conditions (Fig. 7A). These results, together with those showing that similar 
amounts of heterologous myc RNA were present in the transfected cells (Fig. 7A; 
the lower panel depicts quantitative real-time PCR for the myc 3′ UTR), suggest 
that CPEB represses the translation of myc RNA when it has its own CPE-
containing 3′ UTR, and that the levels of myc are important for regulating cell 
senescence. 
These results imply that reduced myc levels in KO MEFs would induce 
senescence. To assess this possibility, a short hairpin RNA (shRNA) was used to 
knock down myc RNA; shRNA for GFP served as a control. Figure 7B (top) 
shows that relative to the control shRNA, the myc shRNA knocked down myc to 
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>95%. A growth curve demonstrates that with reduced myc levels, the cells 
ceased to divide (Fig. 7B, middle panel; the cells are shown in the bottom panel). 
Finally, we also assessed possible apoptosis in MEFs overexpressing myc. 
Although p19ARF and p53 levels were somewhat elevated in these cells, we 
detected no significant apoptosis as assessed by TUNEL labeling or Western 
blotting for several apoptotic markers such as caspase 3, BAX, or BCL-2 
(Supplementary Fig. 2). These data indicate that CPEB-mediated senescence 
occurs via translational control of myc RNA. 
 
Discussion 
This report demonstrates the necessity of CPEB for cellular senescence in 
MEFs. CPEB requires p53, p19ARF, and p16INK4A to induce senescence; 
conversely, activated Ras requires CPEB to stimulate this process. The CPEB 
KO MEFs are not transformed, and while they, like immortalized cells derived 
from wild-type MEFs, are transformed by Ras, their responses to this oncogene 
are not identical. That is, Ras causes the KO MEFs to form more and larger foci 
in soft agar compared with wild-type MEFs, and induces distinct shape changes 
in the KO MEFs in tumors formed in nude mice. While the significance of these 
results remains to be elucidated, they do indicate that immortalized wild-type and 
CPEB KO MEFs are not identical. Indeed, p53, whose disruption is usually 
associated with immortalization, is expressed at normal levels in the KO MEFs. 
 45 
Finally, CPEB interacts with several CPE-containing mRNAs whose encoded 
products are present at aberrantly high levels in the KO MEFs (p130, p107, myc) 
and the translation of one of them, myc, appears to regulate senescence. 
The observation that CPEB is essential for cellular senescence is surprising. 
Several other proteins have been implicated in this process including eIF4E 
(Ruggero et al. 2004), a general factor that regulates all cap-dependent 
translation. Thus, the number of mRNAs whose translation could be affected by 
eIF4E overexpression is extremely large. CPEB, on the other hand, interacts only 
with CPE-containing RNAs, thus vastly restricting the potential mRNA substrates 
on which it could act to induce senescence. Even so, the identification of myc 
RNA as one substrate involved in this process was unexpected because its 
translation is reported to be under internal ribosome entry site (IRES) control, 
while CPEB mediates translation through eIF4E (see introduction and below). On 
the other hand, myc has long been known to regulate cell proliferation; it is low in 
nondividing cells and high in rapidly dividing cells (Campisi et al. 1984). Its 
overexpression can enhance the cell cycle, especially by shortening G1 (Karn et 
al. 1989), but can induce apoptosis as well (Thompson 1998). MEFs and other 
cells lacking myc have a reduced rate of proliferation (Mateyak et al. 1999). Our 
results show that a two-to threefold elevation in myc levels caused by the 
aberrant translation of its mRNA when the CPEs are deleted can lead to 
senescence bypass. Conversely, we show that a knockdown of myc causes 
MEFs to stop dividing. 
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We also examined the effects of myc overexpression on apoptosis in MEFs. In 
wild-type and KO MEFs, over-expressed myc induced a mild up-regulation of p53 
and p19ARF, but we could detect no evidence of apoptosis (Supplementary Fig. 
1). It is known that myc overexpression can induce apoptosis, as noted above, 
but in our case, myc may not have been at a sufficiently high level to induce 
apoptosis. Moreover, in the CPEB KO MEFs, perhaps other factors whose 
translation is controlled by CPEB are reduced or enhanced, which could offer 
some protection against apoptosis. 
 
Translational control by CPEB 
How CPEB might repress myc translation may be gleaned from its activity in 
other cells. In Xenopus oocytes, an RNP complex includes CPE-containing RNA, 
CPEB, Maskin, and eIF4E, among other proteins. Through its association with 
CPEB, Maskin prevents translation of CPE-containing RNAs by preventing the 
interaction between eIF4E and eIF4G (Cao and Richter 2002). This repression is 
reversed when CPEB is phosphorylated by Aurora A on S174 (frog) or T171 
(mouse) (Mendez et al. 2000; Tay et al. 2003). Because a T171A CPEB mutation 
rescues senescence, the phosphorylation of this residue, if it occurs in MEFs, 
cannot be necessary for the translational regulatory event by CPEB that 
mediates senescence. CPEB could still use Maskin-like molecules to repress 
translation. In this regard, a new CPEB and eIF4E-binding factor has been 
identified in Xenopus, mouse, and human cells. This protein, neuroguidin, 
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represses translation in a CPE-dependent manner (Jung et al. 2006), and thus 
could mediate the activity of CPEB that is necessary for senescence. 
CPEB also interacts with the RNA helicase p54 (Minshall et al. 2001). This 
protein inhibits translation by an unknown mechanism, but its activity may be 
related to its residence in p-bodies (Coller and Parker 2005). p-bodies, or 
processing bodies, were first shown to be centers for RNA destruction (Sheth 
and Parker 2003), but are now known to harbor translationally dormant mRNAs 
as well (Brengues et al. 2005). Recent evidence indicates that in HeLa cells, 
CPEB is present in p-bodies (Wilczynska et al. 2005). We have confirmed that in 
MEFs, CPEB is also present in p-bodies, among other regions in the cell (data 
not shown). While we do not know if myc RNA is also present in p-bodies, we 
speculate that it might be. Conversely, myc RNA might not be p-body associated 
in CPEB KO MEFs, thereby resulting in elevated levels of translation. It should 
also be noted that myc RNA contains an IRES (Stoneley et al. 1998), and thus its 
translation would require neither eIF4E nor eIF4G. However, myc RNA is also 
translated by cap-dependent translation, and the mode of translation it uses, cap 
versus IRES, is cell type dependent (Stoneley et al. 2000). 
 
Is CPEB a tumor suppressor? 
As determined by the absence of growth without serum, in soft agar, or in nude 
mice, the CPEB KO MEFs are not transformed. On the other hand, the KO MEFs 
 48 
transformed with Ras grow faster in medium containing serum, form larger foci in 
soft agar, and yield unusually shaped cells in nude mice compared with wild-type 
cells expressing Ras. These results suggest that MEFs lacking CPEB are slightly 
more susceptible to Ras-mediated transformation than CPEB-containing MEFs. If 
this is the case, then the CPEB KO mice might contract cancer at a higher rate 
than wild-type mice, especially if they express activated Ras or perhaps are 
exposed to a chemical mutagen. While neither wild-type nor CPEB KO animals 
aged nearly a year show signs of cancer (data not shown), experiments will be 
initiated to assess whether oncogenes or other carcinogens elicit an elevated 
rate of malignancy in the CPEB KO mice. 
 
Material and Methods 
 
Reagents 
Mouse CPEB (Gebauer and Richter 1996) was cloned into the XhoI–NotI sites of 
C-POZ, a retrovirus vector (Nakatani and Ogryzko 2003), or into the XhoI sites of 
pMSCVhyg (Clontech Laboratories, Inc.). The c-myc ORF, with or without its own 
3′ UTR (a gift from Michael Cole, Dartmouth Medical School, Hanover, NH), was 
cloned into the BamHI–EcoRI sites of pBabe, a retrovirus vector (Morgenstern 
and Land 1990). The myc 3′ UTR was cloned into the XbaI–NotI sites 
of Renilla luciferase (pRL-TK; Promega). 
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Antibodies for cyclin E (C19), cyclin A (H432), cyclin D1 (DCS-6), Rb (IF8), p107 
(C18), p130 (C20), and p21 (C19) were a gift from Andrew Koff (Memorial Sloan-
Kettering, New York) and are designated according to Santa Cruz Biotechnology. 
Other antibodies were purchased from commercial suppliers (c-myc, sc764, 
p16INK4A, M-156 from Santa Cruz Biotechnology; p19ARF, ab80–100, Abcam; the 
hemagglutinin epitope, PRB-101P, Covance; phospho-Rb, Ser 887/811, Ser 795, 
Ser 780, Cell Signaling; tubulin, Sigma). 
 
Cell culture and immunostaining 
Wild-type, CPEB+/−, and CPEB−/− MEFs were derived from E12.5–E14.5 embryos 
and cultured in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum 
using a 3T3 protocol. The cells were infected (Danos and Mulligan 1988) with 
retroviral vectors C-POZ mCPEB, pBabe-c-Myc-Puro, pMSCV-mCPEB-Hyg, and 
pMSCV-Ki-Ras-Puro (gift from Valentina Evdokimova, University of British 
Columbia, Vancouver, BC, Canada), which were packaged using Bosch and 
Phoenix cells (Pear et al. 1993). To knock down myc, cells were infected with 
retrovirus pMSCV-puro into which the myc shRNA (or as a control, GFP shRNA) 
was cloned (Open Biosystems, clone SM2166 H-3). The infected cells were 
selected with 2 μg/mL puromycin or 400 μg/mL hygromycin, or by using magnetic 
beads containing antibody against the IL3 receptor, which is expressed on the 
surface of cells infected with C-POZ retrovirus vector (Nakatani and Ogryzko 
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2003). CPEB in pMSCV-Hyg was also introduced to p19ARF KO, 
p16INK4A/p19ARF KO (gifts from Norman E. Sharpless, University of North 
Carolina, Chapel Hill, NC), and p53 KO (gift from Stephen Jones, University of 
Massachusetts Medical School, Worcester, MA) MEFs at passage 4. 
Senescence-associated β-galactosidase activity was determined at pH 6.0 (Dimri 
et al. 1995). Soft agar assays were performed according to Clark et al. (1995). 
To visualize the microtubules, wild-type and CPEB KO MEFs at passages 3 and 
25 were immunostained with primary antibody against α-tubulin and secondary 
antibody conjugated with green Alexa Fluor 488 (Molecular Probes). DNA was 
stained with DAPI. The coverslips were mounted with Prolong (Molecular 
Probes), and images were obtained with a Nikon Eclipse (E600) microscope at 
100×. 
The TUNEL reaction was performed using an In Situ Death Detection POD kit 
(Roche). DNase I-treated cells were used as a positive control. 
 
Biochemical assays 
Wild-type MEFs were infected with a retrovirus encoding Flag-and HA-tagged 
CPEB. Cells obtained from 150 mM plates were lysed in buffer containing 20 mM 
Tris-HCl (pH 8), 0.2 mM EDTA, 0.1% Tween 20, 0.1 M KCl, 10% glycerol, 10 mM 
β-mercaptoethanol, and protease inhibitors and subsequently subjected to RNP 
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coimmunoprecipitation sequentially with antibody directed against each epitope 
(Nakatani and Ogryzko 2003). The RNA was extracted from the final precipitate 
and subjected to an RT reaction with SuperScript II (Invitrogen) with an oligo(dT) 
primer. 
Renilla luciferase was cloned into pRL-TK vector (Promega) mRNA and 
appended with either the myc 3′ UTR (the myc 3′ UTR sequence is found in 
Ensembl ENSMUST22971) or a 3′ UTR derived from vector sequence; the RNA 
was synthesized in vitro with T7 RNA polymerase (mMassage mMachine kit; 
Ambion). Each of these RNAs was mixed with RNA encoding firefly luciferase 
appended with a 3′ UTR vector sequence and transfected into wild-type and 
CPEB KO MEFs with Trans-Messenger Transfection Reagent (Qiagen). The 
amount of Renilla luciferase in each of the MEFs was then determined 4 h after 
transfection with the Dual-Luciferase Reporter Assay System (Promega) and 
expressed as a fold change in CPEB KO versus wild-type MEFs. 
Wild-type and CPEB KO MEFs were infected at passage 2 with pBabe-c-Myc-
Puro (myc ORF with its own 3′ UTR or one with a vector 3′ UTRone) or pBabe-
Puro (vector alone). The levels of myc mRNA and protein were assessed by the 
RT–PCR reaction and Western blotting, respectively. Total RNA or protein was 
prepared from 100 mM plates of MEFs cultured to passage 4. One microgram of 
total RNA was used for RT–PCR or quantitative real-time one-step RT–PCR with 
the QuantiTect SYBR RE-PCR Qiagen kit. The relative fold changes were 
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calculated using the 2−ΔΔCt method. Western blot analyses were performed on 
one-fourth of the material from cells grown on 100 mM plates. 
Polysome fractionation was performed according to Ruan et al. (1997). MEFs at 
passage 4 were obtained from three 10-cm plates and were centrifuged through 
15%–50% sucrose and fractionated, and the RNA from each fraction was 
extracted and used for oligo(dT)-primed quantitative real-time PCR for myc and 
actin RNAs. The amount of myc RNA was normalized to the amount of actin 
RNA in each fraction. Relative fold changes were calculated using the 
2−ΔΔCt method. 
For UV cross-linking (Hake and Richter 1994), [32P]UTP-labeled myc 3′ UTR (20 
fmol) was mixed with recombinant CPEB (1 μmol) plus 0, 3, 6, and 30 pmol of 
competitor RNA (cyclin B1 3′ UTR containing or lacking the CPE) and irradiated 
with UV light. The RNA was then digested with RNase A and T1, and the 
products were resolved by SDS-PAGE and PhosphorImaging. 
 
Mice and histology 
Immortalized wild-type and CPEB KO MEFs, some of which were infected with a 
Ki-Ras-expressing retrovirus, were injected subcutaneously into 12-wk-old male 
athymic (nude) mice (Charles River) (~106 cells per injection, one injection near 
each hind limb of each of 10 mice). The mice were euthanized 6 wk post-
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injection, and the tumors were dissected, weighed, fixed, and processed for 
histological analysis. Paraffin-embedded sections were stained with hematoxylin 
and eosin. 
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Figure 1. CPEB controls senescence in MEFs. (A, left) A Western blot of wild-
type (WT) and CPEB KO MEFs probed for CPEB and tubulin. (Right) The rate of 
population doublings of four CPEB KO MEF lines and, for comparison, one wild-
type line and one CPEB heterozygous line. The MEFs were cultured according to 
a 3T3 protocol. (B) Wild-type and CPEB KO MEFs were infected with a retrovirus 
expressing HA-tagged CPEB, or an empty control vector, at passage 2 and then 
fixed at passage 4 (wild type) or passage 11 (KO) and stained for β-
galactosidase activity. Also shown is a Western blot demonstrating the 
expression of HA-tagged CPEB in wild-type and KO MEFs. (C) MEFs lacking 
CPEB, p19ARF, p16INK/p19ARF, or p53 were infected with the CPEB-encoding 
virus or an empty vector at passage 4 and examined by phase contrast 
microscopy at passage 11. (D) MEFs derived from wild-type, CPEB KO, and 
p19ARF KO animals were infected at passage 2 with a retrovirus expressing Ki-
Ras or an empty vector, selected by puromycin at passage 3, and examined by 
phase contrast microscopy at passage 5. 
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Figure 2. CPEB KO MEFs have features consistent with partial transformation. 
(A) Wild-type (WT) and CPEB KO MEFs were examined by phase contrast 
microscopy and immunostained for α-tubulin at passages 3 and 25 (P3 and P25) 
to assess cell morphology. The cells were also stained with DAPI to visualize 
nuclei. (B) Wild-type and CPEB KO MEFs were cultured for up to 5 d in medium 
containing 1% or 10% serum and analyzed for cell number by staining with 
crystal violet (average ± SD, n = 3). Some of the MEFs were also infected with a 
retrovirus expressing Ki-Ras and were similarly examined. (C) Wild-type and 
CPEB KO MEFs, some of which were infected with a Ki-Ras-containing virus or 
an empty virus vector as before, were grown on soft agar for 2 wk. Small foci 
were estimated to have ~100 cells, while large foci were estimated to have 
~500–1000 cells. 
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      Figure 3 
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Figure 3. Tumors derived from wild-type (WT) and CPEB KO MEFs transformed 
with Ki-Ras. Immortalized cells derived from wild-type MEFs grown according to 
a 3T3 protocol as well as CPEB KO MEFs were infected with a retrovirus 
expressing Ki-Ras. The cells were injected subcutaneously into athymic (nude) 
mice (five mice each, two injections per mouse near each hind limb). All Ki-Ras-
containing cells formed tumors irrespective of genotype (10/10 WT, 10/10 CPEB 
KO). (A) Representative pictures of the tumors at the sixth week after injection; 
note the hematoma on the tumors derived from the CPEB KO MEFs (cf. those 
denoted by arrows). All 10 tumors derived from the Ras-transformed KO cells 
had hematomas. (B) Tumor growth. (C) Final tumor and mouse weight 6 wk after 
injection. (D) The tumors shown in A were excised, sectioned, and stained with 
hematoxylin and eosin. Representative sections are shown. The arrows denote 
cells with enlarged cytoplasm and displaced nuclei. 
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Figure 4. Expression levels of proteins involved in the cell cycle and cell 
senescence. Wild-type (WT) and CPEB KO MEFs were collected over passages 
2–8 and examined by Western blot ting for the indicated proteins. Tubulin served 
as the loading control and as a standard for film exposures among blots. Be 
cause the p53 antibody reacted strongly with two proteins from wild-type and 
CPEB KO MEFs, extracts from p53 KO and parallel wild-type MEFs were also 
analyzed. The faster migrating protein was absent from the p53 KO MEFs, 
demonstrating that it is p53. (NS) Nonspecific band. 
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Figure 5. RNA binding but not phosphorylation is necessary for CPEB rescue of 
senescence. The CPEB KO MEFs were infected with virus expressing no CPEB 
(Vec), wild-type CPEB (WT), CPEB lacking the RRMs (ΔRRM), CPEB lacking 
the zinc finger (ΔZF), or CPEB with T171A/S177A mutations that prevent 
cytoplasmic polyadenylation. The cells were selected and counted on days 3 and 
6. The Western blot shows the relative levels of the virally expressed proteins 
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Figure 6. Translational regulation of myc mRNA by CPEB. (A) MEFs were 
infected with Flag-and HA-tagged CPEB and subsequently subjected to RNP 
coimmunoprecipitation sequentially with antibody directed against each epitope. 
The RNA was extracted from the final precipitation and subjected to RT–PCR for 
the denoted RNAs. In addition to the immunoprecipitated RNP complexes, total 
RNA from wild-type (WT) and KO MEFs was serially diluted and analyzed for 
RNA levels by RT–PCR. (Right) The relative input levels of the RNAs by RT–
PCR from wild-type, CPEB KO, and CPEB KO MEFs that were infected with 
virus expressing CPEB. (B) 32P myc 3′ UTR was mixed with recombinant CPEB 
and, in some cases, with CPE-containing (CPE+) or CPE-lacking (CPE−) RNA. 
The mixture was UV-irradiated, RNase-digested, and analyzed by SDS-PAGE 
and PhosphorImaging. (C) MEFs infected with the same plasmids as in A were 
mixed with CPE-containing (CPE+) or CPE-lacking (CPE−) RNAs prior to HA 
immunoprecipitation and RT–PCR for myc RNA. (D) Wild-type and CPEB KO 
MEFs at passage 4 were centrifuged through sucrose gradients and fractionated, 
and the myc and actin RNAs in each fraction were determined by quantitative 
real-time PCR. The histogram depicts the amount of myc RNA relative to actin 
RNA in each fraction. The UV scans of the gradients (absorbance at 254 nm) are 
depicted at the top. (E) Schematic diagram of Renilla luciferase RNA appended 
with either the myc 3′ UTR (the CPEs and the polyadenylation hexanucleotide 
AAUAAA are shown) or a 3′ UTR derived from vector sequences but containing 
the AAUAAA. Each of these in vitro synthesized RNAs was mixed with RNA 
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encoding firefly (FF) luciferase appended with a 3′ UTR vector sequence, and 
transfected into wild-type and CPEB KO MEFs. The FF luciferase construct 
served as an internal control for transfection efficiency. The amount of Renilla 
luciferase in each of the MEFs was then determined 5 h after transfection and 
expressed as the fold change in CPEB KO versus wild-type MEFs. The average 
of three experiments (±SD) is shown. 
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Figure 7. Myc RNA translation by CPEB controls senescence. (A) At passage 2, 
wild-type (WT) and CPEB KO MEFs were transfected with a retrovirus 
expressing the myc-coding region appended with its own 3′ UTR or a 3′ UTR 
derived from vector sequences. Some MEFs were infected with a virus 
containing only the vector. At passage 7, cell number was assessed by 
microscopy and by counting with a hemocytometer. Some of the cells were also 
used for Western blotting for myc and tubulin, and for RT–PCR of the myc ORF 
and 3′ UTR. In addition, the myc 3′ UTR was quantified by real-time PCR 
(histogram). The levels of this RNA were made relative to actin RNA, which was 
also quantified by real-time PCR. (B, top panel) KO MEFs were infected with 
shRNAs for myc or GFP at passage 2 and puromycin-selected, and a Western 
analysis for myc protein was performed at passage 5. The cells were also 
examined for population doubling (middle panel) and phase contrast microscopy 
(bottom panel). 
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Supplementary Figure 1 
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Supplementary Figure 1. Cell cycle rates of WT and CPEB KO MEFs.  Cells of 
each genotype at passage 2 were cultured in medium lacking serum for 24 hours 
and then cultured a subsequent 29 hours in medium containing 10% serum.  At 
several times, the cells were stained with propidium iodide and subjected to 
FACS analysis. 
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Supplementary Figure 2 
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Supplementary Figure 2.  Immunoblots of p53, p19ARF, Bax, BCl2, Caspase 3, 
cleaved Caspase 3 and tubulin were performed on WT and KO MEFs that were 
infected with retroviruses harboring the sequences noted above.  The right panel 
shows TUNEL reactions for the cells infected with the sequences noted above.  
PI, propidium iodide. 
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Abstract 
CPEB is a sequence-specific RNA binding protein that regulates 
cytoplasmic polyadenylation-induced translation.  We report here that 
CPEB KO mice are hypersensitive to LPS-induced endotoxic shock, which 
correlates with elevated serum levels of the proinflammatory cytokines IL-
6, IL-8 and IL-12. Peritoneal macrophages from the KO mice, as well as a 
CPEB-depleted macrophage cell line, not only secrete more IL-6 than 
control cells in response to LPS, but also have prolonged retention of NFκB 
in the nucleus, which is responsible for elevated IL-6 transcription.  The 
amount of nuclear NFκB correlates with reduced levels of IκBα, which is 
hyperphosphorylated and rapidly degraded.  Collectively, these data 
suggest that CPEB deficiency enhances the inflammatory response via 
delayed resolution of NFκB signaling. 
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Introduction 
Inflammation is triggered by bacterial pathogens and lipopolysaccharide 
(LPS), a component of their cell walls, which activates the transcription of 
multiple inflammatory response genes including cytokines and chemokines. 
Despite the importance of these inflammation mediators for the host defense 
against infection, their uncontrolled excessive production can elicit multiple organ 
failure and lethality resulting in septic shock. Therefore, the limitation of cytokine 
production provides an essential step in the termination of inflammation and the 
prevention of endotoxic tissue damage (Aggawat et al., 2003; Medzitov et al., 
2008).  
Production of the inflammatory mediators is controlled at multiple levels 
including transcription, translation, and protein stability (Anderson, 2009). In the 
presence of LPS, the immune response is triggered through a Toll-like receptor 
(TLR) signaling pathway (Kawasaki et al., 2003) resulting in the activation of 
several transcription factors including NFκB (Xiao and Ghosh, 2005 ). Many 
signaling events that converge on NFκB lead to the activation of the IκB kinase 
(IKK) complex (Mercurio et al., 1997; Zandi et al., 1997), which in turn 
phosphorylates IκBα, a factor that normally retains NFκB in the cytoplasm 
(Stancovski and Baltimore, 1997). Phosphorylated IκBα is rapidly destroyed, thus 
releasing NFκB to translocate to the nucleus and activate transcription of target 
genes (Hoffmann et al., 2006). In addition to the activation of transcription, LPS 
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triggers the stabilization of multiple mRNAs, an event that is dependent upon the 
interplay of several 3’UTR-binding proteins such as those that associate with the 
AU-rich element  (ARE) stabilization/destruction sequence (Zhang et al., 2002; 
Akira et al., 2006; Hao and Baltimore, 2009). 
The Cytoplasmic Element Binding Protein, CPEB, is an mRNA binding 
protein that interacts with the CPE, a U-rich sequence in mRNA 3’UTRs to 
control poly(A) tail length and translation (Hake et al.1994; Richter 2007 ). As a 
consequence of its control of polyadenylation and translation, CPEB regulates 
germ cell development (Tay et al. 2001), neuronal synaptic plasticity (Alarcon et 
al. 2004, Klann and Richter 2007), and cellular senescence ( Groisman et 
al.2006, Burns et al.2008). Two observations suggested that CPEB might also be 
involved in the immune response.  First, CPEB activation by phosphorylation is a 
result of extra-cellular signaling events including those induced by stress such as 
that which occurs during cellular senescence. Second, the ARE, a 3’-UTR cis-
element in cytokine mRNAs resembles the CPE, indicating that CPEB might 
influence their stability and/or translation.  In this report, we have investigated 
CPEB involvement in the immune response.  We find that CPEB KO mice are 
hypersensitive to endotoxic shock and that they secrete high levels of cytokines.  
Peritoneal macrophages derived from the KO animals, as well as a macrophage 
cell line depleted of CPEB produce excessive amounts of the cytokines.  We find 
that cytokine production is due to an aberrantly long nuclear retention of NFκB, a 
transcription factor that induces cytokine mRNA synthesis.  IκBα, a protein 
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required for cytoplasmic NFκB retention, is hyperphosphorylated and destroyed 
at an abnormally high rate upon CPEB depletion, thereby liberating NFκB for 
nuclear translocation and transcriptional activation.  
 
 
Results and Discussion 
 
LPS induction of high levels of serum cytokines results in septic shock 
(Krakauer et al.,2010).  To determine whether CPEB might be involved in this 
inflammatory response, the peritoneal cavities of wild type (WT) and CPEB KO 
mice were injected with LPS LD50. The rate of LPS-induced lethality of the KO 
mice was substantially elevated relative to that of WT animals, and reached 
100% by day 6 (Figure 1A). Both WT and KO animals had normal levels of white 
blood cells and platelets prior to LPS injection (data not shown), indicating no 
obvious predisposition to inflammation.  Histological analysis of liver and lung 
tissue samples taken 24 h after LPS injection revealed an increased number of 
neutrophils in both WT and CPEB KO animals. However, the levels of neutrophils 
in the KO samples were significantly higher, indicating an especially strong 
inflammatory response (Figure 1B). Next, we analyzed the levels of blood serum 
cytokines after control PBS or LPS injection by performing ELISA for 96 different 
mediators of inflammation. Only 6 of the 96 showed a statistically significant 
change; of these 6, IGF-bp3, IGF-1, IL-6, IL-12, and IL-8 (KC) were little altered 
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upon PBS injection irrespective of genotype. L-selectin, was elevated in the 
serum in both PBS and LPS injected KO mice. LPS injection elicited significantly 
higher levels of IL-6, IL-8, IL-12p40, IGF-1, and IGF-BP3 in the KO animals 
(Figure 2).  Interestingly, the proinflammatory cytokines IL-6, IL-8 and IL-12p40 
are major markers of lethal sepsis, which correlate with the increased lethality on 
the LPS injected CPEB KO mice.  To begin to determine why the cytokine levels 
were abnormally elevated in the KO mice, we analyzed immune cell lineages 
from thymus, lymph node, and spleen by FACS.  In no case did we observe any 
significant difference in immune cell progenitors or mature immune cells (data not 
shown).  Because macrophages are one major source of cytokine production, we 
analyzed IL-6 from wild-type and CPEB KO mice-derived peritoneal 
macrophages treated with LPS in vitro. As shown in Figure 3A, LPS-induction of 
IL-6 in the KO macrophages was elevated by ~2 fold, which is consistent with the 
results observed in the KO animals.  We also assessed the level of IL-6 after 
shRNA-mediated depletion of CPEB in a macrophage cell line (RAW264.7), 
which has an inflammatory response to LPS similar to that of primary 
macrophages. As shown in Figure 2B, the level of CPEB RNA in cells infected 
with lentivirus expressing shRNA for CPEB was strongly reduced compared to a 
scrambled control shRNA. Although LPS induced IL-6 in control and lentivirus-
shCPEB infected cells, depletion of CPEB resulted in ~3 fold higher levels of this 
cytokine. Because LPS induces a transcriptional program culminating in 
interleukin production, we used RT-PCR to determine whether CPEB depletion 
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had an effect on LPS induced IL-6 transcription (Figure 3D). LPS elicited 
elevated levels of IL-6 RNA in both control and CPEB depleted cells.  However, 
the CPEB deficient cells had a higher level of IL-6 RNA following LPS treatment, 
suggesting that the level or activity of a transcription factor may be controlled by 
CPEB.   
 NFκB is one of the major LPS-activated transcription factors implicated in 
IL-6, IL-8 and IL-12 cytokine production (Pahl et al., 1999) Moreover, NFκB 
mRNA encoding the 65 kDa subunit (p65, RelA) contains CPEs in its 3’ UTR, 
suggesting that it may be a direct target of CPEB. Consequently, we assessed 
whether NFκB inhibitors could prevent the accumulation of the high LPS-induced 
IL-6 levels in CPEB knockdown cells (Figure 4A).  Although LPS induced >3 fold 
increase in IL-6 in CPEB depleted cells, this increase was abrogated by two 
different inhibitors of NFκB activity, JSH-23 and 5HPP-33.  Thus, NFκB is a 
major contributor to IL-6 production in CPEB deficient cells in response to LPS.   
 Next, because NFκB transcriptional activity is tightly controlled by its 
nuclear localization, we examined the levels of IκBα, a cytoplasmic NFκB 
anchoring protein.  In WT cells, LPS induces a transient decrease in IκBα levels 
(Xiao and Ghnosh, 2005; Mercurio et al., 1997 ); in Figure 4B, IκBα was reduced 
at 0.5 hrs post LPS and returned pre-LPS levels by 4 hours.  Unexpectedly, 
CPEB depletion resulted in a dramatic decrease in the levels of this protein at 0.5 
and 4 hr in response to LPS (Figure 4B).  These results imply that NFκB nuclear 
localization, directly or indirectly, would be regulated by CPEB. To assess this 
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possibility, we immunostained control and CPEB-depleted macrophages for 
NFκB at 0-4 hours post-LPS treatment.  Figure 4C demonstrates that prior to 
LPS administration, NFκB was cytoplasmic in cells containing or lacking CPEB; 
after 30 min however, when IκBα was destroyed, NFκB relocated to the nucleus 
in both cell types.  As expected, in control cells after 4 hr in LPS, IκBα levels 
were restored and NFκB relocated to the cytoplasm. In contrast, LPS-treated 
CPEB knockdown cells in which IκBα levels were low, NFκB remained nuclear.  
We observed similar results in LPS-treated peritoneal macrophages derived from 
WT and CPEB KO mice (Figure 5).  These results suggest that CPEB control of 
IL-6 production in response to LPS is mediated by NFκB subcellular localization. 
Because IκBα mRNA contains 3’ UTR CPEs, we suspected that it might 
be under the translational control of CPEB.  To address this possibility, control 
and CPEB-depleted macrophages were treated with LPS for 4 hours, followed by 
pulse labeling for 15 min with 35S-methoinine and immunoprecipitation of IκBα.  
Knockdown of CPEB had no discernable effect on the synthesis of this protein 
(Figure 6A).  This result suggests that CPEB controls IκBα at the level of protein 
degradation.   
To assess this possibility, control and CPEB deficient cells were incubated 
with LPS and with or without MG132, a proteosomal inhibitor.  Figure 6B shows 
that, as in Figure 4B, there were low levels of IκBα when CPEB depleted cells 
were treated with LPS.  In contrast, IκBα in CPEB depleted cells incubated with 
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the proteosome inhibitor was restored to control levels.  We further examined the 
phosphorylation of IκBα at Ser 32/36, which is required for ubiquitination and 
subsequent degradation (Mercurio et al. 1997).  Indeed, in depleted cells treated 
with LPS and MG132, which maintains IκBα stability, ser 32/36 were hyper-
phosphorylated (Figure 6B).  Based on these data, we propose that CPEB 
knockdown elicits IκBα instability, possibly by activating IKKalpha/beta complex 
or other unknown kinases, resulting in NFκB nuclear retention and IL-6 
transcription (Figure 6C).   
The enhanced degradation of IκBα can be a direct result of either CPEB-
dependent regulation of proteases that control IκBα degradation (such as Skp1–
Culin Roc1/Rbx1/Hrt-1–F-box) (Ben-Neriah, 2002), or CPEB-dependent 
regulation of IκBα or NFκB modifications (such as acetylation, phosphorylation, 
or glycosylation) (Xiao and Ghosh, 2004) that, in turn, lead to IκBα instability.  In 
both cases, we envision that CPEB enhances upstream signaling events that 
culminate in prolonged NFκB nuclear retention.  For example, CPEB could 
control the level or activation of IKKα/β, one of the main kinases that 
phosphorylates IκBα ser32/36, which in turn would mediate the amount of NFκB 
in the nucleus (see above). In addition, a defect NFκB signal termination can 
lead to the prolong activation of this transcription factor.  Some possibilities 
include expression of suppressor cytokine signaling proteins (SOCS1 and 
 83 
SOCS3) (Ilangumaran et al., 2004) and de-ubiquitinating enzymes (A20 and 
Cezanne) (Verstrepen et al., 2010;Enesa et al., 2008).    
In addition to transcription, the inflammatory response is regulated by the 
stability and/or translatability of cytokine mRNAs, which can feedback and 
modulate NFκB activity (Hoffmann and Baltimore, 2006).  A number of RNA 
binding proteins control cytokine RNA expression.  For example, mice lacking 
AUF1, an ARE-binding protein, suffer from dermatitis and chronic inflammation 
(Sadri et al., 2009); when challenged with LPS, the animals have elevated serum 
cytokines, particularly TNFα, and a high rate of mortality (Lu et al., 2006). 
Another ARE binding protein that mediates the inflammatory response is TTP, 
which when deleted in mice, causes an autoimmune response (cachexia, 
arthritis, dermatitis, autoantibody production) and elevated TNFα.  Mice lacking 
TIA-1, another ARE binding protein, exhibit elevated TNFα and, depending on 
the genetic background, arthritis.  Surprisingly, TTP/TIA-1 double knockout mice 
develop severe arthritis and have high levels of TNFα mRNA but reduced 
amounts of TNFα protein ( Phillips et al., 2004) The mRNA encoding AUF1 has 
several CPEs in its 3’ UTR, consequently, we considered the possibility that 
CPEB might mediate the inflammatory response through translational control of 
AUF1 mRNA.  However, AUF1 levels are elevated, not reduced, in CPEB KO 
mice (data not shown), suggesting that CPEB-mediated inflammation does 
involve AUF1.  Moreover, TNFα levels are not significantly altered in CPEB KO 
animals (data not shown).  Thus, while there may be interplay among the various 
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ARE binding proteins for controlling the stability and/or translation of cytokine 
mRNAs, CPEB does not appear to among them. 
Finally, it is interesting to note that only upon LPS treatment, in either 
injected animals or stimulated cells, is CPEB deficiency manifest by elevated 
cytokine production.  This observation suggests that in the non-stressed state, 
CPEB depletion has little detectable effect on inflammation, and that only upon 
the application of stress (i.e., LPS) does CPEB deficiency allow certain signaling 
events to occur without normal constraints, thus leading to dramatic phenotypes.  
In this sense, CPEB might be considered a stress-response protein.  Indeed, 
CPEB deficient primary mouse or human cells do not senesce as do WT cells 
(senescence is a stress response), but are immortal (Groisman et al., 2006; 
Burns and Richter, 2008).  In the brain, CPEB deficiency results in a deficit in 
synaptic plasticity, which is induced by another type of stress, electrical 
stimulation (Alarcon et al., 2004; Zearfoss et al., 2008).  Various signaling events 
may converge on CPEB, or perhaps more properly, CPEB-bound mRNAs, which 
are normally tightly controlled; when CPEB is absent, unrestricted signaling may 
produce a range of phenotypes depending upon the cell or tissue being 
examined. 
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Materials and Methods 
Animal studies  
All experiments were conducted in accordance with approved NIH and 
institutional protocols for the treatment and handling of vertebrate animals. Three 
month old agouti CPEB WT and KO males (13 each with matching littermates) 
were injected IP with LPS (20 mg/kg). The general condition and survival of 
animals were monitored every 12 hours for 6 days. Animal survival rates were 
plotted using Kaplan-Meier method and significance was scored by Log-Rank 
test.  
 
Histology 
For histological analysis, 4 WT and 4 CPEB KO mice were sacrificed 24 hrs post-
LPS injection. Liver and lung tissues were fixed overnight at 4°C in 10% buffered 
formaldehyde, paraffin-embedded, sectioned, and stained with hematoxylin and 
eosin (H&E). 
 
Measurements of cytokine levels 
100 ml of blood were collected from the tail of each animal (4 animals per group) 
following PBS or LPS injection.  Blood serum cytokine levels were determined 
with a cytokine ELISA array (RayBiotech) containing 96 different cytokines. The 
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membranes were probed according the manufacturer’s protocol.  The blots were 
quantified by scanning densitometry. 
IL-6 secretion from primary macrophages or RAW 264.7 cell line was measured 
by mouse anti-IL-6 ELISA (BD Biosience). Equal numbers of macrophages were 
plated in triplicate (5 × 105 cells/well) and were treated with 100 mg/ml LPS 
(Sigma) for 0 to 4 h.  The media samples were collected and used to assess IL-6 
levels by ELISA according to the manufacturer’s protocol 
Antibody 
Immunoblot analysis were performed with purified polyclonal antibodies against 
NFκB (p65) (Santa Cruz Biotechnology), IκBα and pIκBα (Cell Signaling), β-actin 
(Sigma).  
Immunofluorescence 
Macrophages were grown in 12- well tissue culture plates on glass coverslips 
and fixed with 4%formaldehyde, permeabilized with Triton X-100, blocked with 
normal goat serum and stained with NFκB antibody (p65). 
 
Lentiviral production and infections 
Viral stocks were prepared as described (Morgenstern and Land 1990; Kinsella 
and Nolan 1996), using the 293Tcells and the retroviral plasmid vectors 
containing CPEB-shRNA or scrambled-ShRNA in PLL.3 vector. The 
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macrophages were infected for 5 days and the CPEB knockdown was confirmed 
by RT-PCR.   
 
Metabolic labeling of cells 
Cells were incubated in starvation medium (without methionine, 2 mM thymidine, 
no serum) for 15 min and then labeled (150 μCi/mL Redivue 35S-methionine, 
Amersham Pharmacia) for 15 min. Cells were collected, washed 3 times in cold 
PBS and lysed in RIPA buffer. Immunoprecipitations were performed with anti- 
IκBα polyclonal antibody (Cell Signaling) overnight on ice. For some 
experiments, the LPS (1mg/ml) was added to the cells for 4 hours before 
starvation. 
 
Cell cultures  
RAW 264.7 cells were purchased from TACC and were cultured in high glucose 
DMEM containing 10% FBS, and antibiotic/animycotic solution (GIBCO, Grand 
Island, NY) at 37°C in 5% CO2.  To isolate peritoneal cells, mice were injected 
with thioglyconate (3%) for 4 days, after which time the animals were sacrificed 
and the peritoneal cavities were washed twice with 5ml of cold DMEM.  The 
peritoneal cells were collected, centrifuged for 10 min at 1,500rpm at 4°C. The 
cells were resuspended and plated in culture dishes and allowed to adhere for 3 
h.  The cells were then washed twice with PBS to remove debris and 
contaminating cells and used for ELISA and immunofluorescence analysis. 
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Figure 1.  LPS-induced inflammatory response.  A. WT and CPEB KO mice 
(males, 12 weeks of age), were injected IP with LPS LD50 and a Kaplan-Mayer 
survival curve was determined.  The KO mice exhibited statistically significant 
decreased survival (p=0.03).  B. Histological analysis (H&E staining) of liver and 
lung tissue obtained from control and LPS injected WT and KO mice. White 
arrows indicate increased neutrophil infiltration in KO animals following LPS 
injection. 
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Figure 2.  The blood serum cytokine levels in CPEB KO and WT mice.  Blood 
serum was collected from 4 animals per group 2h of post-PBS or LPS injection 
and the levels of 96 secreted proteins were measured by ELISA.  Six of the 
proteins (IGF-bp3, IGF1, L-selectin, IL-6, Il-12, and KC) were consistently 
different between the 4 groups.  The histograms represent the relative 
densitometric values of the proteins that were significantly different among each 
group. (p-value < 0.05 marked with *; n=4) 
 
 
 
           
 
 
 
 
 
 92 
           
A
C
nt
RT-PCR
CPEB
tubulin
KD        Cont 
RAW 264.7B
tubulin
STAT3
JAK2
JAK1
IL-1β
IL-6
Cont   KD    Cont   KD
LPS     0h      0h 4h       4h
RT-PCR
D
Peritonial
macrophages
RAW 264.7
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0h 4h
A
bs
or
ba
nc
e 
(A
 4
50
 m
in
us
 A
57
5)
Time, LPS
Cont
KD
-0.5
0
0.5
1
1.5
2
0h 4h
A
bs
or
ba
nc
e 
(A
 4
50
 m
in
us
 A
57
5)
Time, LPS
WT
KO
             Figure 3  
 
 
 
 
 93 
Figure 3.  Knockdown of CPEB in RAW 264.7 macrophage cell line causes 
increased IL-6 secretion. A. Peretonial macrophages from CPEB KO or WT mice 
were treated with LPS (100 mg/ml) for 0 or 4h, after which time the media were 
collected and processed for IL-6 ELISA. (n=3) B. RAW 264.7 macrophages were 
infected with lentiviruses expressing either a scrambled shRNA (control) or one 
targeting CPEB (KD). Five days post-infection, the cells were treated with LPS 
(100 mg/ml) for 0 or 4h, after which time the media were collected and processed 
for IL-6 ELISA. (n=3)  C.  RNA was extracted from the cells noted in panel B and 
used to examine the level of cpeb mRNA, by semi-quantitative RT-PCR. D. RNA 
was extracted from the cells noted in panel C and used to examine the level of Il-
6 mRNA, by semi-quantitative RT-PCR. The mRNA level of the other 
inflammatory proteins (JAK1, JAK2, STAT3, IL-1b) and tubulin were used as a 
control. 
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Figure 4.  Prolong nuclear retention of NFκB in CPEB-depleted macrophages 
treated with LPS.  A.  Macrophages infected with lentiviruses expressing 
scrambled (control) or CPEB targeting (KD) shRNAs were incubated with two 
different inhibitors of NFκB (JSH-23 and 5HPP-33) for 2 hours followed by 
addition of LPS for an additional 4 hours.  The media were then collected and 
examined for IL-6 by ELISA.  B. Control and CPEB-depleted macrophages were 
treated with LPS for 0, 0.5, or 4 hrs and then process for western blot analysis of 
NFκB (p65), IκBα and tubulin as a loading control. C. Cells treated as described 
above were fixed at the corresponding time points and processed for immuno-
fluorescence for NFκB.  In contrast to control cells, the CPEB-depleted cells 
treated with LPS for 4 hours maintained NFκB in the nucleus.  D.  RNA was 
extracted from cells treated as above and used for RT-PCR analysis of NFκB, 
IκBα, and tubulin. (n=3) 
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Figure 5.  Nuclear retention of NFκB in peritoneal macrophages treated with LPS 
derived from CPEB KO and WT mice.  Peritoneal macrophages were treated 
with LPS for the times indicated, then fixed and immunostained for NFκB (p65).  
250 cells were randomly chosen and scored for nuclear versus cytoplasmic 
NFκB.  The localization of NFκB was determined by comparing with cells 
showing mostly cytoplasmic, mostly nuclear, or even distributed between the two 
compartments.  
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Figure 6. IκBα is hyper-phosphorylated in CPEB-deficient cells following LPS 
treatment.  A. Control and CPEB-depleted cells were treated with LPS for 0 or 4 
hours followed by 15 min incubation with 35S-methionine and subsequent 
immunorecipitation of IκBα.  The panel shows that the rate of synthesis of IκBα is 
unaffected by CPEB depletion or LPS.  Also show is labeled protein from the 
whole cell extract. B. A schematic view of the mechanism of NFκB nuclear 
translocation.Without LPS NFκB retained in the cytoplasm through the interaction 
with IκBα protein. Upon LPS stimulation IκBα is phosphorylated and 
subsequently degraded thus, releasing NFκB that translocates to the nucleus. C.  
Control or CPEB-deficient macrophages were treated LPS and in some cases, 
with the proteosomal inhibitor MG132 for 0-6 hours.  Proteins extracts were then 
western blotted and probed for IκBα, pIκBα, or actin as a loading control.  Note 
that IκBα is hyper-phosphorylated in CPEB knockdown cells treated with LPS 
and MG132.  
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CHAPTER IV 
 
Discussion and Conclusions 
 
In the Chapter II of this dissertation I presented the data that CPEB 
deficient mouse embryonic fibroblasts have an abnormal life span (when cultured 
in vitro) and proliferate without entering the irreversible cell cycle arrest known as 
a senescence.  
This study was initiated from a simple observation that in early 
development in frog oocytes CPEB regulates several cell cycle-related genes, 
including Cyclin B1 and Mos during meiotic and mitotic divisions. Moreover, 
depletion of CPEB results in cell cycle arrest and defects in the mitotic apparatus 
(Groisman et al., 2000). Next, we hypothesized that CPEB may play a role in the 
mammalian cell cycle. As a model for our study we decided to use the CPEB 
knockout mice, which provides a convenient source of CPEB KO cells. With the 
many examples in the literature describing viable knockouts of different cell cycle 
related genes, the fact that CPEB KO mice does not display any obvious 
abnormality ( except a defect in fertility) and has a normal lifespan was not that 
surprising. First, we decided to compare the cell cycle progression of the 
embryonic fibroblasts obtained from CPEB KO and WT mice. To our 
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disappointment, no significant difference in the initial cell divisions between both 
genotypes was found. Surprisingly, after several passages in cell culture we 
observed a reduction of WT cell number and unusual flat cell morphology. At the 
same time we could still culture the CPEB KO cells for many more passages 
without noticing a reduction in proliferation. In fact, what we observed in case of 
WT cells was a well described and studied phenomena named senescence 
(Sharpless et al., 2001).  In our case, CPEB KO cells bypassed senescence and 
displayed unusual round cell phenotype at later passages. To confirm that this 
effect is due to CPEB deficiency, we attempted to rescue senescence in CPEB 
KO cells by CPEB overexpression. In fact, reintroduction of CPEB could restore 
the senescence phenotype (reduced proliferation, flat morphology and 
expression of b-Gal) after a few rounds of proliferation, showing that bypass of 
senescence is CPEB-specific. Senescence is considered to be a protective 
mechanism to prevent uncontrolled cell division and tumorogenesis. Thus, the 
next question was if CPEB KO cells display any characteristics of cell 
transformation. 
In addition, we observed that CPEB KO MEFs are resistant to the premature 
RAS-induced senescence, the effect which is common among the cells with 
altered tumor suppressor pathways. Notably, CPEB KO MEFs infected with the 
Ras oncogene at later passages can form some colonies in soft agar, suggesting 
a possible change toward tranformation. However, injection of these cells to the 
athymic mice leads to the formation of tumors indistinguishable from the 
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matching WT. We were unable to find any significant changes in the level of 
many cell-cycle and senescence related proteins. However, in CPEB KO cells we 
observed an increased amount of c-Myc, an oncogene which possesses a few 
potential CPE-elements in its 3’UTR. In fact, we found that CPEB can regulate 
level of c-Myc via repression of its mRNA. We also found increased levels of the 
RB-related p107 and p130 proteins in CPEB KO cells, however additional 
experiments need to be performed to clarify the significance of these changes. 
Later studies of CPEB function during the human cell senescence (Burns 
et al., 2006) confirmed our initial observations. First, despite the difference in size 
of the telomeres and a life span between mouse and human cells, knockdown of 
CPEB in primary human cells also resulted in bypass of senescence. Second, 
this phenotype can be rescued by CPEB overexpression. Third, human cells 
were also resistant to Ras-induced premature senescence. However, levels of c-
Myc in the human cells were unchanged and CPEB was found rather to regulate 
p53 polyadenylation. 
Collectively this data confirm the role of CPEB in both mouse and human 
senescence and extends our knowledge of CPEB function in mammalian cells. 
Considering the amount of protein containing the putative CPE-elements it is 
likely that CPEB involved in regulation of other senescence related proteins. 
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In Chapter III of this dissertation, I investigated the role of CPEB in LPS-
induced inflammation. As suggested by multiple studies, all stages of the 
inflammatory response including onset, progression and resolution, greatly rely 
on translational control and mRNA stability. Notably, regulated mRNA translation 
provides a rapid and, in most cases, reversible way to regulate protein levels that 
results in acute activation and fast termination of inflammation. Thus, this project 
began with the hypothesis that CPEB, an RNA-binding protein that regulates 
translation, could be involved in the control of protein synthesis during the 
inflammatory response.  
Interestingly, many potential activators of CPEB were shown to have a 
crucial role in immune response. For example, progesterone, the hormone that 
triggers CPEB-dependent polyadenylation in Xenopus oocytes, has a role in the 
alleviation of inflammation. It was shown that pretreatment of macrophages with 
progesterone inhibits LPS-induced expression of inflammatory proteins such as 
IL-6, TLR4, and iNOS and induces the expression of proteins involved in the 
resolution of inflammation such as SOCS1. In addition, GSK-3 activation (a 
kinase that inhibits Aurora A and leads to the formation of inhibitory CPEB 
complex) was shown to promote the IL-6 production in macrophages and in the 
central nervous system where it regulates microglia migration and inflammation 
(Yuskaitis and Jope, 2009). Conversely, inhibiting GSK-3 reduces the 
inflammatory response and has an important clinical application in the treatment 
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of septic shock, chronic inflammatory and neurodegenerative diseases (Ko et al., 
2010). 
In contrast to CPEB, the role of other 3’UTR binding proteins such as 
AUF1, TTP, TIA-1, and HuR in inflammation is well described in the literature. All 
of these proteins bind AU-rich sequences, which in part resembles the CPE 
element (UUUUUAU) and elicit post-transcriptional regulation via the control of 
mRNA stability. Most of ARE-binding protein deficient mice show altered cytokine 
stability (TNFα is the most affected) and have changes in the inflammatory 
response (Anderson, 2010). Consequently, we proposed that CPEB might have 
a similar function in controlling cytokine production.  We also considered the 
possibility of CPEB either working in synergy or competing with ARE-binding 
proteins. Finally, because the 3’UTRs of some ARE-binding proteins (for 
example, AUF1 and HuR) have a multiple CPE-elements we did not exclude the 
possibility of CPEB-dependent control of their expression.   
In our study, CPEB KO mice were found to be less tolerant to IP injections 
of LPS and have an increased influx of neutrophils in the lung and liver indicating 
the presence of a hyperactivated inflammatory response. Currently, there are no 
obvious indications of increased inflammation in CPEB KO mice when raised 
under normal conditions. The CPEB KO mice have a lifespan comparable to WT, 
a total blood count in a normal range, and a similar of immune cell progenitors 
compared to WT. In contrast, LPS, which is a highly potent stimulator of 
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inflammation, elicits the dramatic changes in CPEB KO mice compared to WT. 
This suggest that perhaps an additional strong signal, similar to the one that 
activates CPEB by progesterone in Xenopus oocytes is required to activate the 
CPEB and thus CPEB-dependent control of protein expression. For example, the 
activation of the NMDA receptor is required to activate CPEB-dependent 
translation in neurons.  
  Because LPS elicits the inflammatory response via an increase of multiple 
proinflammatory cytokine production, we compared the cytokine level in CPEB 
KO and WT mice. By performing the ELISA test for 96 inflammatory cytokines, 
we found an LPS-stimulated increase in blood serum level of   IL-6, IL-8, IL-12 in 
of CPEB KO mice. The elevated levels of these cytokines were previously 
described as a “signature” of endotoxic shock and were shown to correlate with 
the increased mortality. Out of 96 cytokines, we could only detect significant 
changes in 6 of them, perhaps due to the limited expression of cytokines at the 
time point we used.  
We also observed that LPS promoted induction of IL-6 the CPEB-deficient 
RAW 267.4 macrophages, a cell line with a fully functioning LPS signaling 
pathway. In addition, we detected an increased amount of IL-6 mRNA in CPEB-
deficient cells, suggesting the increase an IL-6 transcription or mRNA stability.  
LPS stimulated signaling pathways trigger the activation of the NFκB 
transcription factor that has a central role in inflammation. To investigate whether 
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the increased production of IL-6 was NFκB-dependent, we tested whether the 
NFκB inhibitors can reduce the amount of secreted IL-6. In fact, we observed a 
great reduction of IL-6 by the NFκB inhibitors. We proposed that the increased in 
cytokine production is triggered via activation of the common inflammatory 
transcriptional factor NFκB. NFκB activity is tightly controlled by its nuclear 
translocation and is inhibited via binding to IκBα in the cytoplasm. We confirmed 
the NFκB localization and observed its prolonged nuclear retention in CPEB-
deficient macrophages, which correlated with a reduced level of IκBα in CPEB 
KO macrophages. 
After the ruling out the possibility of CPEB-controlled translation of IκBα 
(the rate of biosynthesis of IκBα was unaffected) we conclude that it is likely that 
CPEB regulates proteasomal degradation of IκBα. Moreover, the level of IκBα is 
restored by incubating cells with the proteasomal inhibitor MG132, and we also 
observed a higher level of IκBα phosphorylation at Ser32/36, which was shown 
to be directly linked to the stability of the protein. 
Collectively, we show that deletion of CPEB can lead to hypersensitivity to 
the LPS, increased cytokine production, and prolonged nuclear retention of NFκB 
due to CPEB-dependent control of IκBα protein stability. In this study we focused 
on the activation of a single transcription factor, NFκB, and its regulators, 
however we do not exclude the possibility that CPEB may affect other 
transcription factors known to be involved in cytokine production. For example, 
 108 
transcription factors such as c-Jun and STAT3 have been shown to have 
synergistic effects with NFκB.  
Also the exact mechanism of CPEB-dependent IκBα destabilization is still 
unknown. One possibility includes CPEB-dependent regulation of proteases 
known to control IκBα degradation such as Skp1-Culin Roc1/RBx1/Hrt-1-F-box. 
Another possibility includes enhanced posttranslational modifications of both 
IκBα and NFκB (such as acetylation and phosphorylation) by activated upstream 
signaling molecules, which in turn lead to higher NFκB activity and IκBα 
degradation. The enhanced phosphorylation of IκBα at S32 and S36 residues 
suggests that, perhaps, IKK kinase complex could be the one of the upstream 
signaling molecules.  
Improperly terminated cytokine signaling signals back to NFκB could 
provide a constant input for its activation. Thus, it remains possible that CPEB-
dependent control of cytokine mRNA stability feeds back to NFκB. In addition, 
the lack of terminating signals such as SOCS 1 and SOCS3, histone 
deacetylating enzymes (HDACs), phosphatases (for example PTPs) or 
deubiquitinases (such as A20 and Cezanne), were shown to lead to the 
increased NFκB activation.   
It was recently shown that in human monocytes, reduction in cytokines 
correlates with miRNA inhibition and increased P-bodies formation (after 8 
hours). Because CEPB is also a component of p-bodies the question of whether 
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CPEB represses cytokine mRNA expression in these cytoplasmic structures and 
its relationship to miRNAs is still open. The abundance of CPE-elements in the 
3’UTRs of many mRNAs suggests the complexity of the CPEB signaling network. 
Thus it will be interesting to analyze the CPE content in the early response group 
of inflammatory mRNAs in comparison to the inflammatory genes in the late 
response group. Knowing when and how CPEB is activated in response to the 
LPS can provide us with a greater understanding of CPEB-dependent signaling.  
Finally, the inflammatory pathways overlap with the diabetes and cancer 
pathways, leading to the question of whether CPEB functions under these 
inflammatory conditions. There are some literature reports describing a variety of 
cancers with a significant change in the level of the CPEB interacting protein, 
Symplekin, as well as upstream signaling components (progesterone and 
estrogen receptors, Akt1, GSK-3, Aurora A, parafibromin). 
Transformation of CPEB deficient mouse embryonic fibroblast with the 
RAS oncogene can promote the growth large colonies (foci) in soft agar assays, 
indicating that in this system CPEB may function as a tumor-suppressor.  
However, injection of such fibroblasts into the athymic mice yielded tumors 
indistinguishable from the control cells, showing that this function is not sufficient 
to increase the rate of cancer growth in animals. In contrast, CPEB KO mice are 
more susceptible to formation of papillomas when the chemical mutagens 
DMBA-TPA are applied, suggesting some tissue specificity in cancer 
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progression. In addition, a few reports show that some ovarian cancers have a 
significant change in CPEB mRNA levels, however it is not clear if this difference 
is a cause or consequence of cell transformation.  
At this time, it is difficult to predict the function of CPEB in cancer 
development due to its potential involvement in a bidirectional control of CPE-
containing mRNAs (including oncogenes and tumor suppressors as well as their 
regulators). For example, simultaneous regulation by CPEB of cell cycle proteins 
(cyclin B1), oncogenes (c-Myc) and tumor suppressors (p53) can create a fragile 
balance between normal cell division and cancer progression. 
The normal life span of CPEB KO mice suggests that it is likely that 
additional external DNA-damaging stimuli, leading to tissue specific signaling 
events and changes in multiple genes, will be required for shifting this balance 
toward CPEB-driven tumorigenesis. Elucidating the timing of translational control 
for all specific CPEB-targets can also help us to understand the complexity of 
CPEB-dependent cancer progression. 
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APPENDIX I. 
Centrosomal localization of CPEB4 
CPEB4 is an RNA-binding protein that belongs to the CPEB family of 
proteins; it shares strong sequence similarity to CPEB and to the other family 
members, CPEB2 and CPEB3 (Theis et al., 2003). Similar to CPEB (described in 
early in this dissertation), CPEB4 possesses 2 RRMs and 2 Zn-finger domains 
that are critical for its mRNA binding. However, CPEB4 binds to the CPE with low 
affinity and, instead, has a high specificity to a distinct mRNA sequence with a 
secondary structure resembling a poly(U) loop (Huang et al., 2006). Unlike 
CPEB1, CPEB4 does not have an Aurora A phosphorylation sites, but has 
recognition motifs for some other kinases such as CamKII, PKA and p70S6. This 
suggests that despite its similarity to CPEB1, CPEB4 has a different mechanism 
of regulation and, perhaps, binds to a different subset of mRNA targets. 
Among all CPEB proteins, CPEB4 was shown to be the most abundant in 
hippocampal area of the brain (as detected by mRNA in situ hybridization and 
protein immunostaining) and Purkinje cells of the cerebellum. In hippocampal 
cultured neurons, CPEB4 was associated with mRNA in the form of RNP 
dendritic granules located in the post synaptic density. The mRNA encoding 
CPEB4 in the brain was rapidly induced by kainite, a very potent inducer of 
seizures. CPEB4 is also expressed in immune cells such as macrophages (Raw 
267.4 cell line) (data not shown). In other types of immune cells, e.g., 
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thymocytes, CPEB4 was shown to be a transcription target of ROR gamma, a 
nuclear receptor involved in different physiological aspects including the 
regulation of thymocytes differentiation and circadian rhythms (Xi et al., 2006). 
As suggested from recent work in Xenopus oocytes CPEB4, similar to CPEB1, is 
involved in translational control via polyadenylation (Novoa et al., 2010; Igea et 
al., 2010). In fact both proteins are differentially regulated in early development 
(as shown by a correlation between increased level of CPEB4 and a decreased 
level of CPEB1) with CPEB1 being a prevalent translational regulator during 
early oocyte development and CPEB4 acting as a translational regulator later in 
development (i.e., meiotic arrest) (Igea et al., 2010). In Xenopus oocytes CPEB1, 
which is important for cell cycle progression via regulation of cell cycle related 
proteins such as Mos and Cyclin B1, was shown to mediate the localization of  
these mRNAs to the centrosomes and spindles (Groisman et al.,2000; Eliscovich 
et al., 2008). Moreover the depletion of CPEB1 leads to the multiple centrosomal 
and spindle abnormalities and results in a cell cycle arrest (Groisman et al., 
2000). In addition, exogenous CPEB1 can be co-localized with centrosomes in 
Hela cells (data not shown). Here, we describe centrosomal localization of 
CPEB4 in mammalian cells and begin to characterize the significance of this 
observation. 
This work began from the simple observation that in mammalian cells stained 
with affinity purified CPEB4 antibody, in addition to being dispersed in the 
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cytoplasm, CPEB4 displays a very distinct dot-like cytoplasmic staining pattern, 
resembling the centrosome. In fact, when co-stained with the centrosomal 
marker gamma-tubulin, CPEB4 was shown to be highly co-localized with the 
centrosomes in many different cell types including Hela and RPE cells (Fig.1), 
and HFS or MCF7 cells (data not shown). By using cell lines stably expressing 
GFP-centrin B, a centrosomal marker that unequally localizes to the mother 
centriole, we noticed that the majority CPEB4 co-localizes in an opposite manner 
to CentrinB, i.e, showing specificity to the daughter centriole in a cell cycle stage 
independent manner (Fig.2). Because the centrosome is the major microtubule 
organizing center, staining of some proteins in the centrosome can be a result of 
aggregation of proteins attached to the microtubules. However, CPEB4 
localization to centrosomes was not dependent on microtubules since their 
disruption by nocadozole did not affect CPEB4 localization (Fig 3, upper panel), 
except a modest increase in the number of “dots” observed in some cells. 
However this result does not exclude the possibility that CPEB4 was delivered to 
the centrosome via microtubules. To confirm the specificity of CPEB4 
centrosomal localization, we assessed CPEB4 distribution in Hela cells 
transfected with CPEB4-shRNA. As shown in Fig.4, we observed CPEB4 co-
staining with the centrosomal marker gamma tubulin only in nontransfected cells. 
In contrast, centrosomal staining of CPEB4 was barely detectable in the cells 
transfected with CPEB4-shRNA. To further confirm the specificity of CPEB4 
localization to the centrosome, we biochemically purified centrosomes from Hela 
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cells by using discontinuous sucrose gradients after preincubation  with 1 μg/ml 
cytochalasin D and 0.2 μM nocodazole for 1 h according to the method of  
Moudjou and Bornens (1998) (Wigley et al.,1999).  
 As shown in Fig 3A. CPEB4 was enriched in the both cytoplasmic 
(confirmed with alpha tubulin antibody) and centrosomal (confirmed by gamma-
tubuling staining and HSP proteins 70 and 27) fractions of the gradient.  
Next, we investigated whether CPEB4 depletion has an impact on cell 
cycle progression or the centrosome replication cycle. Compared to cells infected 
with a lentivirus expressed a scrambled shRNA, RPE cells containing a virus 
expressing shRNA for CPEB4 (Fig 5B), we observed a mild arrest in a S-phase 
of the cell cycle, suggesting a possible role of CPEB4 at this stage. However we 
did not observed any cell cycle abnormality when a similar experiment was 
performed in Hela cells (data not shown). In addition we did not find any 
centrosomal cycle defects as both cell lines, irrespective of CPEB4 depletion, 
showed equal centrosomal amplification induced by hydroxyurea (data not 
shown).  
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Figure1. CPEB4 on centrosomes.  A. Asynchronously dividing Hela cells were 
methanol-fixed and immunostained with affinity purified antibodies to CPEB4 
(red), the centrosomal marker gamma tubulin (green), and DAPI (blue). 
Localization of the CPEB4 and gamma tubulin were detected by indirect 
immunofluorescence. B. RPE cells were immunostained as in panel A and 
visualized by spinning disk confocal microscopy followed by 3D image 
reconstruction.  
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Figure 2. CPEB4 preferentially localizes to the daughter centriole throughout the 
cell cycle.  Asynchronously dividing Hela cells were methanol-fixed and 
immunostained with affinity purified CPEB4 antibody and co-localized with stably 
transformed GFP-centrin, a centrosomal marker.  Images were collected by 
confocal microscopy at different stages of the cell cycle. The strongly fluorescent 
dots of GFP-centrin are indicative of mother centrioles. The numbers indicates 
the cells counted.  
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Figure 3. CPEB4 localizes to the centrosome in nocadazole treated Hela cells. 
Hela cells treated with 5µg/ml nocadazole for 3 hours were methanol-fixed and 
immunostained with affinity purified antibodies to CPEB4 and gamma tubulin; 
there were also stained with DAPI (upper panel). To confirm microtubule de-
polymerization by nocadozole, the cells were stained with antibody against alpha 
tubulin (Lower panel). The images were obtained by indirect fluorescence. 
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Figure 4.  shRNA mediated depletion of CPEB4 eliminates its detection on 
centrosomes. Hela cells transfected with lentivirus expressing GFP and shRNA 
were cultured for CPEB4 for 48h, fixed by methanol and stained for CPEB4 (red) 
and gamma tubulin (green). The images were obtained by using confocal z-
section analysis. Note that CPEB4 only localizes to the centrosome in cells 
lacking GFP (and hence the shRNA for CPEB4).  In cells expressing GFP (and 
hence the shRNA for CPEB4), there is no CPEB4 detection on centrosomes. 
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Figure  5. CPEB4 protein co-sediments with the centrosomes. Centrosomes 
were prepared by 20-62% discontinuous sucrose gradient centrifugation as 
described in the text. Equal amounts of fractions 1-8 were collected from the top 
of the gradient and subjected to western blot analysis. The purity of the 
centrosomal preparation was confirmed by alpha-tubulin exclusion from the 
centrosomal fractions. Note that CPEB4 and heat shock proteins Hsp70 and 
Hsp27 (as a controls) co-sediment with the centrosomal protein gamma tubulin 
(fractions 5-7). 
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Figure 6. Cell cycle analysis of CPEB4 deficient RPE cells. A. RPE cells were 
infected with lentivirus expressing shRNA for CPEB4 or scrambled shRNA as a 
control. The cells were exponentially grown for 5 days after infection; CPEB4 
knockdown was confirmed by western blot with CPEB4 antibody. NS denotes a 
nonspecific band, KD refers to shRNA for CPEB4, “cont” refers to a scrambled 
shRNA, “n.i” refers to control cells not infected with a virus. B. Asynchronously 
dividing RPE cells infected with virus expressing shRNA for CPEB4 or scrambled 
shRNA as a control were stained with propidium iodide and analyzed by flow 
cytometry. Note the slight block of the cell cycle in S-phase in CPEB4 deficient 
cells. 
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